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Abbreviations 
 
APS     Ammonium peroxodisulfate 
ATP     Adenosintriphosphate 
Bp      base pair 
BSA     Bovine serum albumin 
cDNA     complementary DNA 
DAPI     4', 6-Diamidino-2-phenylindole 
DMSO     Dimethyl sulfoxide  
DEPC     Diethylpyrocarbonate 
DNA     Deoxyribonucleic acid 
DNase     Deoxyribonuclease  
dNTP     Deoxynucleotidetriphosphate 
dT      Deoxythymidinate 
DTT     Dithiothreitol 
EDTA     Ethylene diamine tetra acetic acid 
FCS     Fetal calf serum 
g      gravity 
GFP    Green fluorescence protein 
g      gram 
HEPES    1-Piperazineethane sulfonic acid 
HPLC     High performance liquid chromatograpy 
IPTG     Isopropyl-ß-thiogalactopyranoside 
kb      kilobase 
kD     kilodalton 
Mb     Mega base pair 
mRNA     messenger Ribonucleic acid 
NaAc     Sodium acetate 
NCBI     National Center for Biotechnology Information 
ng      nanogram 
NLS     Nuclear localization signal 
OD     Optical density 
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ORF    Open reading frame 
Pa      Pascal 
PAGE     Polyacrylamide gel electrophoresis 
PCR     Polymerase chain reaction 
pmol     picomol 
PBS     Phosphate buffer saline 
PBT     Phosphate buffer saline + Tween 
PMSF     Phenylmethylsulfonyl fluoride 
RNA     Ribonucleic acid 
RNase     Ribonuclease 
RNasin    Ribonuclease inhibitor 
rpm     Revolutions per minute 
RT      Room temperature 
RT-PCR    Reverse transcriptase-PCR 
SDS     Sodium Dodecylsulfate 
SDS-PAGE   SDS-Polyacrylamide Gel Electrophoresis 
SV40     Simian Virus 40 
Taq     Thermus aquaticus 
TBE     Tris-Borate-EDTA 
TE      Tris-EDTA buffer 
Temp    Temperature 
TEMED    Tetramethylethylene diamine 
Tris     Tri-hydroxymethyl aminomethane 
U      Unit 
UV     Ultra-violet 
V      Voltage 
w/v     weight/volume 
X-Gal     5-bromo-4-chloro-3-indolyl-ß-galactosidase 
3-AT    3-amino-1,2,4-triazole 
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1 Introduction 
1.1 Craniosynostosis  
Craniosynostosis, the premature closure of one or more cranial sutures, is a congenital 
malformation with a frequency of ~1 in 2,500 infants (reviewed by Wilkie 1997). The 
abnormal skull growth may be associated with raised intracranial pressure, impaired 
cerebral prefusion, airway obstruction, impaired vision and hearing, learning difficulties 
and adverse psychological effects, as well as significant aesthetic deformity (Renier et al. 
1982; David et al. 1996; Gosain et al. 1996). More than 100 different forms of isolated 
craniosynostosis and craniosynostosis syndromes are known, showing etiologic and 
pathogenetic heterogeneity (Winter and Baraitser 1994). In about half of the syndromes, a 
genetic cause has been confirmed or suggested. Most craniosynostosis syndromes with a 
genetic background are inherited as monogenic autosomal dominant traits (Cohen 1993). 
 
1.2 Acrocephalosyndactyly  
The acrocephalosyndactylies (ACS), a subtype of craniosynostosis syndromes form a 
heterogenous group of autosomal dominant disorders, with clinically similar symptoms 
etiology. Coronal or multiple synostosis, as well as partial syndactyly of fingers and/or toes 
are the main clinical features of these syndromes (Winter and Baraitser 1994). The shape of 
the skull is altered depending on which of the sutures are fused prematurely. This leads to 
brachycephaly or short-headness, trigonocephaly, anterior and posterior plagiocephaly, and 
dolichocephaly (Fig. 1). 
On the basis of phenotypic characteristics the acrocephalosyndactylies were divided into a 
typical and an atypical form (Blank 1960). The typical form is Apert syndrome (MIM 
101200), characterized by syndactyly of hands and feet of a special type (complete distal 
fusion with tendency for fusion also of the bony structures). The second group comprises a 
heterogeneous collection of disorders and includes Crouzon (MIM 123500), Jackson-Weiss 
(MIM 123150), Pfeiffer (MIM 101600), and Saethre-Chotzen syndrome (MIM 101400). 
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Fig. 1: Diagram of the sutures of the skull.  Superior view of the normal infant skull. The anterior 
fontanelle is boardered by the metopic, coronal, and sagittal sutures, and the posterior fontanelle is bordered 
by the sagittal and the lamboid sutures. Premature fusion of the sutures leads to an abnormal head shape. 
Compensatory expansion (arrows) occurs particularly at neighbouring unfused sutures (modified from Cohen 
and Maclean 2000). 
 
1.3 The Saethre-Chotzen syndrome (SCS)  
The Saethre-Chotzen syndrome (Acrocephalosyndactyly type III [ACS3]; MIM 101400) 
was first described and named after the authors of its first reports (Saethre 1931; Chotzen 
1932). The craniofacial features of this autosomal dominant disorder include eyelid 
anomalies, isolated coronal or multiple craniosynostosis, hypertelorism, facial asymmetry, 
low frontal hairline, ptosis, strabismus, deviated nasal septum, cleft palate, and small, 
posteriorly rotated ears with prominent crura. The limb abnormalities are often subtle and 
can include brachydactyly, mild cutaneous 2/3 syndactyly of the hands and/or feet, 
Normocephaly 
Trigonocephaly 
Brachycephaly 
   Anterior  
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 Posterior 
Plagiocephaly 
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clinodactyly, single-palmar crease, and broad or bifid halluces with valgus deviation 
(Reardon and Winter 1994). The variability of expression and occasional mild phenotype 
seen in Saethre-Chotzen syndrome patients makes this one of the more difficult 
craniosynostosis syndromes to diagnose clinically. 
The syndrome was mapped to human chromosome 7p21 (Brueton et al. 1992; Lewanda et 
al. 1994; Rose et al. 1994) by linkage analysis in affected families and the determination of 
chromosomal breakpoints in sporadic cases. Howard et al. (1997) and El Ghouzzi et al. 
(1997b) showed first that the Saethre-Chotzen syndrome results from mutations in the 
TWIST1 gene. 
TWIST1 codes for a nuclear DNA-binding protein containing a basic helix-loop-helix 
(bHLH) motif suggesting it most likely functions as a transcription factor. 
 
1.4 TWIST1 gene structure 
In Drosophila the Twist gene was originally identified as one of the zygotic genes required 
for dorso-ventral patterning during embryogenesis; its name is derived from the distorted, 
"twisted" appearance seen in the recessively lethal mutant (Simpson 1983; Nüsslein-
Volhard et al. 1984). The human TWIST1 gene consists of two exons, which are separated 
by an intron of 536 bp nucleotides from position +965 to +1500 downstream of stop codon. 
The first ATG (+315) is followed by an uninterrupted open reading frame of 609 bp that 
ends at +922 including with TAG codon and cover the first exon (GenBank Accession No. 
NM_000474) (Howard et al. 1997), coding therefore for a 202 amino acids protein. Two 
putative TATA boxes are upstream at the transcription start located -32 and/or -110 
nucleotides. The 3’-end of the gene reveals two potential polyadenylation signals at 
positions +1565 and +1915 (Fig. 2). 
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Fig. 2: Schematic representation of the human TWIST1 gene structure. Nucleotide sequence of human 
TWIST1 gene contains two exons separated by an intron. Two TATA boxes (-32, -110) present at upstream, 
and two polyadenylation sites (+1565, +1915) present at the downstream of transcription initiation (Genbank 
Acc.No. NM_000474). 
 
1.5 The Saethre-Chotzen syndrome based on mutations in the human TWIST1 gene 
The Saethre-Chotzen syndrome is based on intragenic mutations, as well as specific genetic 
changes outside the coding region of the TWIST1 gene. These intragenic mutations can 
include nonsense and missense alterations and small insertions, deletions, and duplications 
which resulting haploinsufficiency of the gene (Howard et al. 1997; El Ghouzzi et al. 
1997a). All of the intragenic mutations like missense, deletions, and insertions as well as 
nonsense mutations are located within the coding region; particularly these mutations are 
frequently detected in the highly conserved basic helix-loop-helix domain. No splice site 
mutations, intronic mutations or changes within the second exon have been reported (Gripp 
et al. 2000). Currently, more then 70 intragenic mutations have been reported in unrelated 
SCS patients (Fig. 3) (Gripp et al. 2000; Muenke and Wilkie 2001). 
Recently, two intragenic mutations have been reported in TWIST1 in a child with mild SCS 
and her unaffected father and grandmother (Funato et al. 2005), located within glycine rich 
domain and putative nucleus localization signal of TWIST protein. 
In addition to these intragenic mutations, several translocations and deletions have been 
reported which also caused the Saethre-Chotzen Syndrome (Lewanda et al. 1994; Rose et 
al. 1997; Johnson et al. 1998; Heer et al. 2004). 
Deletions of 3.5-10.2 Mb in the TWIST1 region were identified in SCS patients with mental 
retardation. Since the occurrence of such a mental retardation in SCS patients is atypical, 
this phenomenon cannot exclusively be attributed to the absence of the TWIST1 gene. The 
hypothesis that this learning difficulties is caused by the absence of one or several genes, is 
TATAA (-110) 
TATAA (-32) 
ATG TAG
bHLH +965 +1500 
+1 +315 +636 +795 +922 Intron AATAA (+1565) 
AATAA 
(+1915) 
5‘ 3‘
Exon 1 Exon 2 
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supported in three patients with megabase-sized deletion, which suggests that 
haploinsufficiency of genes neighboring TWIST1 contribute to developmental delay. It is 
appropriate the assumption near that in this region further genes are located, for their 
deletion is responsible for this phenotype (Johnson et al. 1998). A 150 kb deletion of 
TWIST1 gene was detected in a Dutch family (Heer et al. 2004), though these people were 
phenotypically normal. 
Likewise, translocations at the 3'-end of TWIST1 also caused the Saethre-Chotzen 
syndrome. A translocation breakpoint 5 kb 3’ was mapped from TWIST1 gene in a patient 
affected with Saethre-Chotzen syndrome (Krebs et al. 1997) and was also reported in 4 
SCS patients at 3’ which did not interrupt the coding sequence of the TWIST1 gene and 
thus most likely were acting through a positional effect (Rose et al. 1997). 
 
 
Fig. 3: Linear representation of types of mutations and polymorphisms, and their position relative to 
the TWIST1 cDNA sequence. Numbers under the linear graph refer to the codon numbers. A: Mutations in 
the coding sequence. B: Polymorphisms in the coding sequence (Modified from Gripp et al. 2000). 
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In the Real time PCR gene dosage analysis assay of 55 patients with features of Saethre-
Chotzen syndrome, it was found that 11% had deletions of the TWIST1 gene, 2 patients had 
a translocation or inversion at least 260 kb at 3’ of the TWIST1 gene, suggesting the 
presence of position-effect mutations (Cai et al. 2003). The translocation breakpoint region 
is likely causes a position effect perhaps by separating cis-acting regulatory region from 
gene. The position effect phenomenon is likely to abolish or reduce the level of 
transcription of one copy of the gene resulting in haploinsufficiency or reduced protein 
levels at critical stages during development (Krebs et al. 1997, Rose et al. 1997). 
In some patients, much smaller deletions at 3’ of TWIST1 lead to the confusion in the 
diagnosis of SCS with other craniosynostosis syndromes. These frequently arises invisible 
deletions, resulting the variability of expression and phenotypic overlap due to missing 
genotype-phenotype correlations, which make the Saethre-Chotzen syndrome is one of the 
more difficult clinically diagnosis syndrome. 
 
1.6 TWIST protein 
TWIST encodes a basic-helix-loop-helix (bHLH) transcription factor crucial for mesoderm 
development in Drosophila (Thisse et al. 1987). The HLH motif was first identified in the 
murine DNA-binding proteins E12 and E47 (Murre et al. 1989b). The two amphipathic 
helices are separated by a loop of varying length. The HLH region is necessary and 
responsible for protein dimerization. A basic amino acid rich region precedes the first helix 
and is required for DNA binding (reviewed by Kadesch 1993). 
H-TWIST protein contains 202 amino acids (Howard et al. 1997). In an evolutionary 
sequence comparison of humans, mouse, rat, chicken, claw frog, zebrafish and fugu twist 
proteins based on the homology, different highly conserved domains were identified within 
the twist proteins (Spring et al. 2000; Baylies and Michelson 2001; Kosan 2002; Brand et 
al. 2003). 
A novel domain with unknown function, named NSEEE-domain, which is characterized by 
the amino acid sequence NSEEE (position 19-23), is located at the N-terminus. Then two 
conserved motifs with the consensus of a nuclear localization signal (NLS) presents within 
the N-terminal region of the TWIST protein sequence (Godmann 2001). These NLS motifs 
are present at the amino acids positions 37-40 (RKRR; NLS1), and 73-77 (KRGKK; 
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NLS2). A glycine-rich and the basic domain are present at the amino acid positions 80 - 98 
and 108 - 120, respectively. The bHLH domain represents the amino acids position 108-
160, in which HLH domain is located at the amino acids position 121-161. At the very 
close of the C-terminal end of TWIST protein, there is a further evolutionary highly 
conserved WR domain named after two amino acids occurs (Fig. 4). 
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                                     NSEEE-            NLS1 
                             motif 
                  ** 
Fugu rubripes  ------MRDEDCSPMDSAG----NSEEETERQLP---RRGARKRRPTRRSSGGE : 41 
Danio rerio  MFEEEAMHEDSSSPESPVD-SLGNSEEELDRRQP---KRVSRKKRASRKNAE--  : 48 
Xenopus laevis  -----MMQEESSSPVSPVD-SLSNSEEELDKQQ---SKRGCRKRRSARKSPE--  : 43 
Gallus gallus  ----MMQQDESNSPVSPADDSLSNSEEEPDRQQLPSAKRGGRKRRSSRRSAG-- : 48 
Rattus norwegicus -----MMQDVSSSPVSPADDSLSNSEEEPDRQQPASGKRGARKRRSSRRSAGGS : 49 
Mus musculus  -----MMQDVSSSPVSPADDSLSNSEEEPDRQQPASGKRGARKRRSSRRSAGGS : 49 
Homo sapiens  -----MMQDVSSSPVSPADDSLSNSEEEPDRQQPPSGKRGGRKRRSSRRSAGGG : 49 
 
                                          NLS2 
                       ** 
Fugu rubripes  EEEG-----------DTESPSPGTKKCRKSSEGGGG-------SAGSGGSEGSS : 77 
Danio rerio  ---------------DSDSPTPG-KRSKK-------------------CSNSSS : 67 
Xenopus laevis  ---------------DPDSPISV-KRNKK-------------------ASSTGS : 62 
Gallus gallus  --------GAVGAADEPCSPAQG-KRGKK---CGAG----AGGGGGGGSSSGGG : 86 
Rattus norwegicus AGPGGATGGGIGGGDEPGSPAQG-KRGKKSAGGGGG---AGGGGGGGGSSSGGG : 99 
Mus musculus  AGPGGATGGGIGGGDEPGSPAQG-KRGKKSAGGGGGGGAGGGGGGGGGSSSGGG :102 
Homo sapiens  AGPGGAAGGGVGGGDEPGSPAQG-KRGKKSAGCGGG----GGAGGGGGSSSGGG : 98 
 
                                  basic         helix – loop - helix      
 
     ** 
Fugu rubripes  SPELSFDDLQTQRVLANIRERQRTQSLNEAFTSLRKIIPTLPSDKLSKIQTLKL :131 
Danio rerio  SP-QSLEDLQTQRVMANVRERQRTQSLNEAFASLRKIIPTLPSDKLSKIQTLKL :120 
Xenopus laevis  SP-QSFEELQSQRVMANVRERQRTQSLNEAFSSLRKIIPTLPSDKLSKIQTLKL :115 
Gallus gallus  SP-QSYEELQTQRVMANVRERQRTQSLNEAFAALRKIIPTLPSDKLSKIQTLKL :139 
Rattus norwegicus SP-QSYEELQTQRVMANVRERQRTQSLNEAFAALRKIIPTLPSDKLSKIQTLKL :152 
Mus musculus  SP-QSYEELQTQRVMANVRERQRTQSLNEAFAALRKIIPTLPSDKLSKIQTLKL :155 
Homo sapiens  SP-QSYEELQTQRVMANVRERQRTQSLNEAFAALRKIIPTLPSDKLSKIQTLKL :151 
 
                     WR-motif 
 
Fugu rubripes  AARYIDFLCQVLESDELDGRGTSCSYVAHERLSYAFSVWRMGGAWSLSTTSH   :183 
Danio rerio  AARYIDFLCQVLQSDELDSKMSSCSYVAHERLSYAFSVWRMEGAWSMS-TSH   :171 
Xenopus laevis  ASRYIDFLCQVLQSDELDSKMASCSYVAHERLSYAFSVWRMEGAWSMS-ASH   :166 
Gallus gallus  AARYIDFLYQVLQSDELDSKMASCSYVAHERLSYAFSVWRMEGAWSMS-ASH   :190 
Rattus norwegicus AARYIDFLYQVLQSDELDSKMASCSYVAHERLSYAFSVWRMEGAWSMS-ASH   :203 
Mus musculus  AARYIDFLYQVLQSDELDSKMASCSYVAHERLSYAFSVWRMEGAWSMS-ASH   :206 
Homo sapiens  AARYIDFLYQVLQSDELDSKMASCSYVAHERLSYAFSVWRMEGAWSMS-ASH   :202 
 
Fig. 4: Evolutionary alignment of vertebrate Twist proteins. Alignment of amino acid sequences encoded 
by the Twist gene from different species (F. rubripes, D. rerio, X. laevis, G. gallus, R. norvegicus, M. 
musculus, and H. sapiens) shows the well known basic Helix-Loop-Helix (bHLH) motif, and four additional 
protein regions in TWIST. The NSEEE-motif is a highly conserved sequence domain in all vertebrate species 
analysed at the N-terminal of the protein. The function is still unknown. NLS1 and NLS2 mark putative 
nuclear localization signals. WR-motif at the C-terminal of the protein shows remarkable conservation 
between all species. Gaps are indicated as hyphens. Black boxes indicate identical amino acids which are 
present in all species. Grey boxes are present in identical amino acid in six species and light grey boxes in five 
species, respectively. Asterisk indicates two amino acids (serine and proline) at three positions in the protein 
which showed high conservation in all species which could be of structural importance for the protein. 
Multiple sequences alignment was generated by ClustalW. 
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1.7 Twist functions  
In vertebrates, the basic helix-loop-helix (bHLH) transcription factor TWIST is involved in 
cell type determination and differentiation during myogenesis (Olson 1990), neurogenesis 
(Anderson et al. 1997), cardiogenesis (Thomes et al. 1998), hematopoieses (Lister and 
Baron 1998), and osteogenesis (Murray et al. 1992; Cserjesi et al. 1995). These bHLH 
transcription factors form either homo-or heterodimer with other bHLH proteins. The 
dimers bind to the E-box core sequence (CANNTG), on the promoter region of target gene 
through the basic region (Murre et al. 1989b). 
The sutures are the primary sites of osteoblast differentiation and bone formation during 
development of the skull. TWIST down regulated expression suggest that its expression 
maintains cells in an osteoprogenitor or a preosteoblast like state, thus preventing 
premature or ectopic osteoblast differentiation (Lee et al. 1999). It has also been reported in 
mouse that TWIST protein is expressed early in the undifferentiated mesenchymal layer 
beneath the epidermis that develop into a distinct dermal layer at later stages (Füchtbauer 
1995). Morriss-Kay et al. (2001) postulated that the balance between proliferation and 
differentiation is based on complicated molecular signal transduction cascades, in which the 
transcription factor TWIST as well as the fibroblast growth factors (FGFs) and their 
receptors (FGFR) play key roles. 
It is well known that TWIST protein bind the myogenic factor MyoD and negatively 
regulates its activity (Spicer et al. 1996; Hamamori et al. 1997). TWIST mutations R120A, 
R122A, R124A disrupted the interaction between TWIST and MyoD and inhibit the MEF2 
transcription factor, a cofactor of myogenic bHLH proteins (Hamamori et al. 1997). 
Twist-null mice die at embryonic day 11.5 due to defects in the head mesenchyme, somites, 
limb buds, and failure of neural tube closure in the cranial region (Chen and Behringer 
1995). Twist-heterozygous mice display skull defects resulting in poorly developed 
squamosal bones and of over-developed intra parietal bones and limb abnormalities. 
Heterozygote Twist mutants (+/-), however, exhibited mild phenotypes at the hind limbs 
and anomalies of head, which are comparable to those of the human Saethre-Chotzen 
syndrome (Bourgeois et al. 1998; Spring et al. 2000). 
Firulli et al. (2005) reported that the heterodimers of TWIST1 and Hand2, basic helix-loop-
helix (bHLH) transcription factor proteins required for the limb development. The 
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dimarization partner choice can be modulated by altered threonine and serine, which are 
highly conserved in the helix I domain of TWIST proteins and necessary for the protein 
kinase A and protein phosphatase 2A-regulated phosporylation. Furthermore, they 
confirmed that altered threonine and serine leads to the development of SCS symptoms in 
mouse and chick models. 
N-terminal domain of M-Twist directly binds 2 independent domains of histone 
acetyltransferases (HAT), p300 and p300/CBP-associated factor (PCAF) and regulates their 
HAT activities (Hamamori et al. 1999). Histone acetyltransferases (HATs) play a critical 
role in transcriptional control by relieving of repressive effects of the chromatin (Struhl 
1998). 
At the C-terminal of Twist protein a highly conserved WR motif was characterized in the 
evolutionary alignment (Kosan 2002). The anti osteogenic function of the Twist proteins 
was mediated by a Runx2-binding ‘Twist box’ (aa 183-202) characterized at the C-
terminus. TWIST proteins transiently inhibit Runx2 function during skeletal development 
in mice. Twist1 and Twist2 were expressed in Runx2-expressing cells throughout the 
skeleton during early development, and osteoblast-specific gene expression occurred only 
after their expression decreased. Double heterozygotes for Twist1 and Runx2 showed none 
of the skull abnormalities observed in Runx2 (+/-) mice, a Twist2 null background rescued 
the clavicle phenotype of Runx2 (+/-) mice, and Twist1 or Twist2 deficiency led to 
premature osteoblast differentiation (Bialek et al. 2004). 
TWIST protein is reported as a negative regulator of NF-κB activation. NF-κB has been 
linked to numerous human diseases, especially cancer, because of the elevated expression 
of genes encoding antiapoptotic proteins, cytokines, chemokines, and cell adhesion 
molecules. TWIST1 and TWIST2 repress cytokine gene expression through interaction with 
RelA/p65. These factors bind DNA at kB sites and regulate expression of many genes with 
different biological functions. Twist mainly affects the transcriptional activity of nuclear-
translocated NF-κB by competing with cofactors or directly preventing the tethering of 
histone acetyltransferases (HATs) by NF-κB subunit RelA/p65 (Chen 2004).  
Mouse homozygous for a Twist2 null allele or doubly heterozygous for Twist1 and Twist2 
alleles showed elevated expression of proinflammatory cytokines, resulting in perinatal 
death from cachexia. There is an evolutionarily conserved signalling circuit in which 
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TWIST proteins regulate cytokine signalling by establishing a negative feedback loop that 
represses the NF-κB-dependent cytokine pathway (Fig. 5) (Sosic et al. 2003). 
 
 
Fig. 5: Twist as a negative modulator of cytokine expression. Twist activation by NF-κB is part of an 
evolutionarily conserved pathway involved in mesoderm formation and dorsoventral (DV) patterning. While 
NF-kB plays a role in the immune response in both flies and mammals, twist has been adopted as a repressor 
of cytokine expression in mammals (Sosic et al. 2003) 
 
Recently, it is repoted that TWIST plays an essential role in metastasis in a murine breast 
tumor model. Suppression of TWIST expression in highly metastatic mammary carcinoma 
cells specifically inhibited their ability to metastasize from the mammary gland to the lung. 
Ectopic expression of TWIST resulted in loss of E-cadherin mediated cell-cell adhesion, 
activation of mesenchymal markers, and induction of cell motility, suggesting that TWIST 
contributes in metastasis by promoting an epithelial-mesenchymal transition (EMT). In 
human breast cancers, high TWIST expressions were correlated to invasive lobular 
carcinoma, a highly infiltrating tumor type associated with loss of E-cadherin expression 
(Yang et al. 2004). 
(Dorsal) 
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1.8 Aims of the study 
Twist protein seems to be one of the key regulator of development and the process of 
epithelial-mesenchyme transition (EMT) during tumorgenesis. Two NLSs has been 
recognized at the N-terminal of Twist by sequence homology. Nuclear localization has lead 
to the concept that transport across the nuclear envelope is mediated by nuclear localization 
signals. Regarding the nucleus transport of TWIST, the possibility exist an important 
inspection point that a functional loss of the TWIST protein can be attributed to the 
inhibition of nuclear import and thus lead to an abnormal subcellular distribution. 
Furthermore, NLS-binding proteins allow the transport of NLS containing protein to the 
nucleus. From that point of view, functional domains particularly NLSs of the bHLH 
transcription factor TWIST should be analyzed. 
It is evident from the literature about the involvement of cell type-specific bHLH proteins 
in the control of tissue-specific gene expression in vertebrates. For the better understanding 
of the involvement of TWIST in different regulatory pathways, the knowledge of the 
interacting partners during the regularization processes with TWIST is necessary. Possible 
interacting partners for TWIST and its motifs may be helpful to find out the TWIST role in 
various regulatory pathways. The objectives of the study can be devised as described 
below: 
1.  The first aim of thesis is to characterize the functionality of bHLH transcription factor 
TWIST NLSs using two criteria: that TWIST NLSs are sufficient to promote nuclear 
accumulation of an otherwise cytoplasmic protein when fused to it genetically or 
biochemically; in counterpart genetically altered NLSs leads to its cytoplasmic 
retention. 
2. The second aim of the thesis is designed to find out the TWIST protein interactions 
using the protein-protein interaction methodology i.e. Yeast-Two-Hybrid assay. One 
of the most promising interacting partners was examined in the connection by further 
investigations for its functionality in the regulation of a target gene by TWIST using a 
combination of genetic and fluorescence microscopic approaches. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Equipments 
ABI Prism 310 Genetic Analyzer    Applied Biosystems, Foster City, USA 
ABI Prism 377 DNA-Sequencer     Applied Biosystems, Foster City, USA 
Balance Model 2254       Sartorius, Göttingen 
Balance PM 2000        Mettler, Switzerland 
Cryostat           Julabo labortechnik GmbH, Seelbach 
Centrifuge 5417 R        Eppendorf, Hamburg 
Centrifuge 5415 C        Eppendorf, Hamburg 
Megafuge 1.0         Heaeus, Osterode 
Centrifuge Sorvall GLC-2B      Du Pont, Dreieich 
Cooling centrifuge, Sorvall RT 6000     Du Pont, Dreieich 
ECPS 500/400 Fluorometer TKO 100 Hoefer Scientific Instruments, San 
Francisco, USA 
Electrophoresis Constant Power Supply   Pharmacia, Uppsala, Sweden 
Hamilton pipette   Hemilton, Bonaduz, Switzerland 
Horizontal Electrophoresis System   Owl Scientific, Inc., USA 
Incubator Shaker, Model G25   New Brunswick Scientific co, 
    Edison,USA 
Incubator, CO2-Auto-Zero   Heraeus; Hanau 
Incubator for bacterial culture    Heraeus; Hanau 
Laminar Air Flow        Heraeus; Hanau 
Laminar Air Flow        Heraeus; Hanau 
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Sterilebank Microflow Intermed     Stolco, Düsseldorf 
Sterilebank Lamin Air HA 2448 GS    Heraeus, Hanau 
Mini Trans-Blot         Bio-Rad Laboratories GmbH, München 
Microscope Axioplan       Zeiss, Jena 
Microscope Axiophot Epifluoresnence   Zeiss, Jena 
Mini-Protean 3 Cells       Bio-Rad Laboratories GmbH, München 
pH meter CG 836        Schott, Hofheim 
Gene Quant II, Photometer      Pharmacia Biotech, Sweden 
Pharmacia Novospec II, Photometer    Pharmacia Biotech, Sweden 
Spectrophotometer, Smartspec 3000    Bio-Rad Laboratories GmbH, München 
Thermocycler PE 9600       Applied Biosystems, Foster City, USA 
TRIO-Thermoblock TB1      Biometra, Göttingen 
Gradient Cycler         Bio-Rad Laboratories GmbH, München 
Water bath type 3042       Köttermann, Hänigsen 
Water bath type 1083       GFL, Burgwedel 
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2.1.2 Chemicals 
Alexa Flour 488 phallodin   Molecular-Probe Europe EV, Leiden,  
            The Netherlands 
Compelete Mini, Protease Inhibitor cocktail  Roche Molecular Biochemicals,    
            Mannheim 
Triton X-100         Serva, Heidelberg 
Tween-20           Sigma, Deisenhofen 
DMSO           Serva Reinbiochemica, Heidelberg 
Long Ranger Gel solution      Bio Whittaker Molecular Application  
            Rockland, USA 
IGEPAL (NP 40)        Vysis Inc., Downers Grove, USA 
TEMED          Serva Reinbiochemica, Heildelberg 
Salmon sperms DNA        Sigma, Deisenhofen 
SDS            Serva, Heidelberg 
Vectashield Mounting Medium     Vectors laboratories Inc.,     
            Burlingame,USA 
3-amino-1,2,4-triazole (3-AT)      Sigma, Deisenhofen 
 
2.1.3 Buffers and solutions  
Sterilization of solutions and equipments  
All solutions that are not heat sensitive were sterilised at 121°C for 20 min in an autoclave 
(Webeco, Bad Schwartau). Heat sensitive solutions were filtered through disposable sterile 
filter (0.2 to 0.45 µm pore size). Plastic wares were autoclaved as above. Glass wares were 
sterilized overnight in an oven at 220°C. 
 
6.6 µM Alex Fluor 488 Phalloidin   300 units Phalloidin (200 units/ml) was   
           diluted in 1.5 ml methanol and store at –20° C 
Comassie Blue Gel Stain     0.04% Coomassie blue R-250 (w/v) in   
           methanol /acetic acid/aqua dest  
           (40/10/40, v/v/v) 
Comassie Blue Gel Destain     Methanol/Acetic acid/H20 (10/10/80 v/v/v) 
DAPI stock solution (250 ng/ml)   15 µl DAPI /50 ml 0.5% Tween-20/PBS 
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1M DTT         1.542 g DTT in 10 ml 0.01 M NaOAc pH 5.2 
           and store at –20°C 
 
6 X Loading Buffer       50% glycerol (v/v) 
           0.1 M  EDTA 
           0.1% SDS (w/v) 
           0.05%  bromo-phenol blue (w/v) 
           0.05% xylene cyanol FF (w/v) 
5 X TBE Buffer        0.5 M Tris 
           0.5 M Boric acid 
           10 mM EDTA 
 
TE Buffer         10 mM Tris/ HCl 
           1 mM EDTA 
 
10 X PBS (pH 7.4)       29.6 mM Na2 HPO4.7H20 
           10.6 mM KH2PO4 
           1.55 M NaCl 
 
PBS-Tween 20        0.5% Tween-20 (v/v) in PBS 
 
PMSF stock solution      0.25mM dilute in isopropanol 
           and store at –20° C 
 
Buffer A for Protein Extraction    10 mM HEPES 
           1.5 mM MgCl2 
           10 mM KCl 
           adjust the pH 7.9 with KOH 
           before use add 0.5 mM DTT and 0.2 mM  
           PMSF 
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Buffer C for Protein Extraction    20 mM HEPES 
           1.5 mM MgCl2 
           420 mM NaCl 
           0.2 M EDTA 
           adjust the pH 7.9  with KOH 
           25% Glycerine (v/v) 
           before use add 0.5 mM DTT 
           0.2 mM PMSF 
 
3 X SDS-PAGE Loading Buffer    0.5 M Tris/HCl (pH 6.8)  
           20% Glycerol  
           0.4% SDS  
           10% β-Mercaptoethanol 
 
Transfer Buffer        39 mM Glycine 
           48 mM Tris 
           0.037% SDS (w/v) 
           20% Methanol 
 
Tris- Glycin protein electrophoresis    250 mM Glycine 
Buffer          25 mM Tris 
           0.1% SDS (w/v) 
 
2.1.4 Enzymes  
All restriction enzymes were obtained from New England Biolabs, Schwalbach. 
Calf Intestinal Alkaline phosphatase (CIAP) Gibco BRL, Life Technologies, Karlsruhe 
T4 DNA Ligase        New England Biolabs, Schwalbach 
RNase H         Roche Molecular Biochemicals, Mannheim 
Taq DNA Polymerase      Amersham Pharmacia Biotech, 
           Piscataway, NJ, USA 
Lyticase         Fa. Sigma, St. Louis, USA 
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2.1.5 DNA and protein size standards  
100 bp DNA Ladder      Gibco BRL,Life Technologies, Karlsruhe 
1 kb DNA Ladder       Gibco BRL, Life Technologies, Karlsruhe 
Multicoloured protein markers wide range New Life Science Products, Boston, USA 
 
2.1.6 Oligonucleotides 
The PCR primers were designed using the online program Primer 3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3 www.cgi). All synthetic oligonucleotides 
were supplied by SIGMA. The optimal annealing temperature was also calculated using the 
primer 3 software (Table 1). 
 
Table 1: Oligonucleotides used for amplification of different cDNA constructs 
Gene Genebank Primer 
name 
Sequence Anneling 
Temp. 
Product 
size 
TWIST1 NM000474 Twist F 
Twist R 
ccggaattccggctagtgggacgcggacat 
ccgcgatgatgcaggacgtgtcc 
60°C 630 bp 
E12 M31222 E12 F 
E12 R 
ccggaattccggatggcgcctgtgggcaca 
cgcggatccgccgcatgtgcccggcggggttgt 
65°C 1900 bp 
TCF4 NM003199 Tcf4 F 
Tcf4 R 
ccggaattccggatgcatcaccaa 
cgcggatccgcgcatctgtcccat 
60°C 1966 bp 
ETV5 NM004454 Etv5 F 
Etv5 R 
ccggaattccggatggacgggttttatgatcag 
cgcggatccgaggtaagcaaagccttcggcata 
60°C 1500 bp 
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Table 2: Oligonucleotide used in yeast-two-hybrid assays for TWIST cDNA and its 
domain: The oligonucleotide served as primers for the PCR, which are specified in this 
work. 
Target Primer 
name 
Sequence Anneal. 
temp. 
Product 
size 
TWIST Y2hTW F 
Y2hTW R 
CCGGAATTCCGGatgatgcaggacgtgtcc 
CGCGGATCCGCGcgtgggacgcggacatg 
60°C 630 bp 
TWIST WR 
domain 
Y2hWR F 
Y2hWR R 
CCGGAATTCCGGctggcggccaggtacatc 
CGCGGATCCGCGcgtgggacgcggacatg 
60°C 250bp 
TWIST NSE 
domain 
Y2hNSE F 
Y2hNSE R 
CCGGAATTCCGGatgatgcaggacgtgtcc 
CGCGGATCCGCGgcgcagacttcttgccgc 
60°C 270 bp 
Yeast mated 
clones 
5 LD Inscr 
3 LD Inscr 
ctattcgatgatgaagataccccaccaaacccac 
aagtgaacttgcggggtttttcagtatctacg 
57°C variable 
Capital latter represent nucleotide endonuclease linkers  
 
Table 3: Oligonucleotide for the sequencing of cloned TWIST cDNA and TWIST domains 
in yeast vector used in yeast-two-hybrid assay 
Target Vector name Primer 
 name 
Sequence Annealing 
temp 
DNA-BD seq- 
Primer 
pGBKT7 (bait) DNA-BD 
primer 
taagagtcactttaaaatttgtat  56°C 
Bait Forward pGBKT7 (bait) T7 taatacgactcactatagggcga 56°C 
DNA-AD seq- 
Primer 
pGADT7(prey) 3’AD Primer agatggtgcacgatgcacag 55°C 
5-LD seq-
primer 
PGADT7 
(prey) 
5-LD primer cgatgatgaagataccccac 56°C 
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Table 4: Oligonucleotides used for site-directed mutagenesis to create the point mutations 
in TWIST cDNA 
Mutation Clone  
name 
Primer 
name 
Sequence Annealing 
temp 
K38R NLS1 mut NLS1 F 
NLS1 R 
cgcgggggacgcaggcggcgcagcagc 
gctgctgcgccgcctgcgtcccccgcg 
55°C 
K73R 73NLS2 mut 73NLS2 F 
73NLS2 R 
cccagggcaggcgcggcaagaagt 
acttcttgccgcgcctgccctggg 
55°C 
K76R 76NLS2 mut 76NLS2 F 
76NLS2 R 
caagcgcggcaggaagtctgcgg 
ccgcagacttcctgccgcgcttg 
55°C 
K77R 77NLS2 mut 77NLS2 F 
77NLS2 R 
gcggcaagaggtctgcgggct 
agcccgcagacctcttgccgc 
55°C 
 
 
Table 5: Primers used for the proof of endogenous TWIST expression and cDNA synthesis  
Primer  Sequence (5’-3’) Extension  
cycle 
Product size 
(cDNA) 
TWIST- f 
TWIST-r 
cgc gga tcc gcg aga tga tgc agg acg tgt cc 
ccg gaa ttc cgg agt ggg acg cgg aca tgg acc a 
30 635 bp 
GAPDH-f 
GAPDH-r 
cgt ctt cac cac cat gga ga 
cgg cca tca cgc cac act tt  
30 300 bp 
 
 
Table 6: Oligonucleotide used for verification of fusion of TWIST with c-myc  
Primer  Sequence (5’-3’) Number of 
cycles 
Product size 
PCMV3C/twist f 
PCMV3C/twist r 
gag cag aaa ctc atc tct gaa gag g 
aca cgt cct gca tca ttc ttc ga 
35 70 bp 
 
   Materials and Methods 
- 23 - 
2.1.7 Vectors 
pBluescript -II-KS-Phagemid vector   Stratagene, Heidelberg 
pCMV- Tag epitope tagging     Invitrogen, Groningen, Netherlands 
eGFP, Mammalian expression vector  Invitrogen, Groningen, Netherlands 
PCR 2.1 TOPO vector      Invitrogen, Groningen, Netherlands 
PGBKT7 Bait vector      Fa. Clontech, Palo Alto, USA 
pGADT7-Rec         Fa. Clontech, Palo Alto, USA 
 
2.1.8 Kit Systems 
DYEnamic ET Terminator Cycle    Amersham Pharmacia Biotech, 
Sequencing Kit         Piscataway, USA 
ECL Western blotting analysis system   Amersham Pharmacia Biotech, Piscataway,  
           USA 
ECL Western blotting detection reagents  Amersham Pharmacia Biotech, Piscataway,  
           USA 
ECL+Plus Western blot detection reagents Amersham Pharmacia Biotech, Piscataway, 
USA 
Immunoprecipitation Kit (Protein G)   Roche Molecular Biochemicals 
QIAfilter Plasmid Maxi Kit      QIAGEN, Hilden 
QIAprep Spin Miniprep Kit      QIAGEN, Hilden 
QIAquick PCR Purification Kit     QIAGEN, Hilden 
QIAquick Gel Extraction Kit     QIAGEN, Hilden 
Ready-To-Go PCR Beads      Amersham Pharmacia Biotech, Piscataway,  
           USA 
Superscript First-Strand Synthesis System  Gibco BRL, Life Technologies, Karlsruhe 
for RT-PCR 
TOPO TA Cloning Kit       Invitrogen, Groningen, Netherlands 
QuikChange Site Directed     Stratagene, Cedar Creek, USA 
Mutagenesis Kit 
Effectene Transfection Reagent     QIAGEN, Hilden 
Matchmaker Yeast-2-Hybrid System   Clontech, Palo Alto, USA 
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2.1.9 Bacterial System  
MAX Efficiency DH5α competent cells  Gibco BRL, Life Technologies, Karlsruhe 
Genotyp: SupE44 lacU169 (80lacZM15)  
hsdR17 recA1 endA1 gyrA69 thi-1 
relA149 (Sambrook et al. 1989) 
 
SUBCLONING efficiency      Gibco BRL, Life Technologies, Karlsruhe 
DH5α competent cells 
(Genotyp: F- _80dlacZ_M15 _(lacZYA-argF) 
U169deoR recA1 endA1 hsdR17 (rK-,mK+)  
phoA supE44 _- thi-1 gyrA96 relA1.) 
 
2.1.10 Antibiotic stock solutions 
Ampicillin          100 mg/ml in H2O  
Kanamycin          20 mg/ml in H2O  
Chloramphenicol        25 mg/ml in EtOH 7.5µg/ml  
All antibiotics stock solutions listed above were sterile filtered and stored at -20°C. 
 
2.1.11 Nutrition medium and media plates 
All bacterial medium were prepared with aquadest and autoclaved.  
Bacterial medium: 
LB medium (Sambrook et al. 1989)   10 g/l Bacto-Tryptone 
           5 g/l Bacto-Yeast Extract 
           5 g/l NaCl 
           1000 ml H2O 
LB-Agar          LB-medium with 15 g/l Bacto agar 
SOB-Medium         20 g/l Bacto tryptone 
           5.0 g/l Bacto yeast extract 
           0.5 g/l NaCl 
           10 ml 250 mM KCl 
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SOC Medium         20 g/l Bacto tryptone 
           5.0 g/l Bacto yeast extract 
           0.5 g/l NaCl 
           10 ml 0.25M KCl 
           5 ml 2M MgCl2 
           20 ml 1M Glucose 
           pH 7.0 with NaOH 
 
NZY+-Medium         10 g/l NZ-Amine (Caseinhydrolysate) 
           5 g/l Yeast extract  
           5 g/l NaCl 
           2g/l MgSO4.7H2O  
           adjust pH 7.5 with NaOH 
 
Yeast medium: 
YPD-medium         20 g/l Bacto peptone  
           10 g/l yeast extract  
           10 g/l glucose 
           autoclave at 121°C for 15 min  
YPDA-medium: For the production of YPDA medium, 15 ml sterile filtered 0.2 % 
adeninehemisulfate was added into the YPD medium.  
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Dropout medium 
Synthetic Drop-out (SD-)      Medium 425 ml SD-Bases 
           50 ml 10x Dropout Supplement 
           adjust pH 5.8 with NaOH 
           autoclave at 121°C for 15 min  
           25 ml 40% (w/v) glucose (sterile filtered) 
 
10x-Dropout Supplement: 10x-Dropout supplement solution consist of individual amino 
acids as well as adenine and uracil, by which those components, on whose auxotrophy 
genes is to be selected, are omitted in each case (“dropped out”). A solution with all amino 
acids consists of: 
L-Adenine hemisulfate       200 mg/l  
L-Arginine HCl        200 mg/l  
L-Histidine HCl monohydrate     200 mg/l  
L-Isoleucine         300 mg/l  
L-Leucine          1000 mg/l  
L-Lysine HCl         300 mg/l  
L-Methionine         200 mg/l  
L-Phenylalanine        500 mg/l  
L-Threonine         2000 mg/l  
L-Tryptophan         200 mg/l  
L-Tyrosine          300 mg/l  
L-Uracil          200 mg/l  
L-Valine          1500 mg/l  
It omitted for: 
SD-Trp:  Tryptophan (for AH109 S. cerevisiae) 
SD-Leu:  Leucine (forY187 S. cerevisiae) 
DDO (-Double Dropout, two-fold selective medium): Leucine and Tryptophan 
four-fold selectively (-Quadruple Dropout-,  four-fold selective medium): Leucine, 
Tryptophan, adeninhemisulfate and histidine HCl mono hydrate 
The dropout solutions were autoclaved at 121°C for 15 min and stored at 4°C. 
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2.1.12 Yeast strains 
Table 7: Yeast strains used in this study for yeast-two-hybrid screening 
S. N. Genotype Source 
1  AH109 competent S. cerevisiae 
MATα ura3-52 leu2-3, 112 trp1-901 his3-200 
ade2-101 gal4∆ met- gal80∆ 
URA3: GAL1uas-GAL!tata-lacZ MEL1 
 
Clontech (Heidelberg) 
Harper et al. 1993 
2 Y187 pretransformed S. cerevisiae 
MATa ura3-52 leu2-3, 112 trp1-901 his-200 gal4∆ 
gal80∆ 
LYS2: GAL1uas-GAL1tata-HIS3                   
          GAL2uas-GAL2tata-ADE2 
URA3: MEL1uas-MEL1tata-lacZ MEL1 
Clontech (Heidelberg) 
James et al. 1996 
 
2.1.13 Human cell-line 
U2-OS Osteosarcoma cells (ATCC HTB-96) 
(Origin: Homo sapiens). The U2-OS-cell line obtained from American Type Culture 
Collection. 
 
2.1.14 Cell culture: medium, salts, and transfections reagents  
DMEM with Glutamax I,     Gibco, LifeTechnologies, Karlsruhe 
           (4500 mg/L D-Glucose, without Sodium  
           pyruvate) 
Penicillin/Streptomycin       Gibco, LifeTechnologies, Karlsruhe 
Fetal Calf serum       Roche molecular biochemicals,     
           Mahnheim 
10% DMEM        440 ml DMEM 
           50 ml fetal Calf serum 
           5 ml nonessential aminoacids 
           5 ml Penicillin/Streptomycin 
Effectene Transfection Reagent     QIAGEN GmbH, Hilden 
PBS-EDTA         0.02 % EDTA in PBS 
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0.05 % Trypsin per 1 Liter     0.5 g Trypsin 
           2.69 g tri-sodiumcitrate-dihydrate 
           6.0 g NaCl, adjust the pH 7.8  
Culture bottles, bowls, six-hole culture plates (six well plates), tubes, culture chamber 
slides (lab Tek II Chamber Slide) were obtained by the companies Greiner, Frickenhausen, 
Nalge Nunc international, Naperville the USA and Becton Dickinson, USA. 
 
2.1.15 Antibodies 
Table 8: Antibodies for detection of TWIST-cmyc constructs 
Name of antibody Organism Company 
Monoclonal anti-c-myc,  
mouse IgG1 
Mouse Molecular probes, Eugene, 
Oregon, USA 
Texas-Red anti mouse IgG Goat Molecular probes, Eugene, 
Oregon, USA 
anti-Mouse-IgG, Texas-Red 
conjugated 
Mouse Kaninchen Sigma, Saint- 
Louis, Missouri USA 
Anti-mouse-IgG, Horseradish-
Peroxidase linked antibody 
Sheep Amersham Biosciences, 
Piscataway, USA 
Monoclonal Anti-human-c-myc 
(clone 9E10) 
Rabbit AG Dr. Frank Seeber, FB 
Biology, Philipps-Universität,  
Marburg 
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2.1.16 Fluorochrome used for fluorescence detection  
Table 9: Reagents used for fluorescence microscopic detection of different cell 
compartments 
Target Fluorochrome Absorption Emission Dye 
Cell nucleus DAPI 358 nm 461 nm Blue 
F-Actin Alexa Fluor 488 495 nm 519 nm Green 
TWIST-c-myc- 
fusion protein 
Texas Red 596 nm 620 nm Red 
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2.1.17 Databases and software used for sequences analysis  
 
For the analysis and the characterisation of the nucleotides and aminoacids sequences 
following internet sources were used. 
 
Table 10: Web links and programmes used for the biometrics analysis 
Appliance Databases/ 
programme 
Resources/links 
Literature search PubMed *NCBI www.ncbi.nlm.nih.gov/entrez  
Comparisons 
Amino acid sequences 
Nucleotide sequences 
 
Blast 
Blast p 
Blast n 
*NCBI 
www.ncbi.nlm.nih.gov/blast 
Inquiries 
Protein function 
Protein domains 
Protein sequences 
SWISS-PROT  **SIB 
SWISS-PROT www.expasy.ch/sprot  
Informations  
Protein families 
Protein domains 
and their functions 
PROSITE  **SIB www.expasy.ch/prosite 
Homology 
Amino acids sequences 
MultAlin www.protein.toulouse.inra.fr/ 
multalin/multalin.html 
Genome data bank UCSC http://genome.ucsc.edu 
Primer design software Primer3 primer/primer3_www.cgi 
 
*National Center of Biotechnology Information (NCBI) 
**Schweizerisches Institutes of Bioinformatics (SIB) 
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2.2 Methods 
2.2.1 Isolation of plasmid DNA (Sambrook et al. 1989, Sambrook et al. 2000)  
2.2.1.1 Small-scale isolation of plasmid DNA (adapted from Birnboim and Doly 1979) 
A single E.coli colony was inoculated in 5 ml of LB medium with the appropriate antibiotic 
and incubated in a shaker for 16 hrs at 37°C. One militre of saturated culture was used for 
making glycerol stock and rest of the culture was sedimented by centrifugation for 15 min 
at 13000 x g. The pellet was resuspended in 250 µl of solution P1. The bacterial cells were 
lysed with 250 µl of P2 solution and than neutralised with 350 µl of solution P3. The 
precipitated solution was incubated on ice for 15 min, and centrifuged at 13000 x g at 4°C. 
The supernatant was transferred into a new tube, and 1 ml of 100% isopropanol was added 
to precipitate the DNA. It was then incubated on ice for 15 min, centrifuged for 20 min, and 
the pellet was washed with 70% ethanol. After air-drying dissolved in 30 µl of TE buffer or 
dH2O.  
P1:           50 mM Tris/HCl (pH 8.0)  
           10 mM EDTA  
           100 µg/ ml RNase A  
 
P2:           200 mM NaOH  
           1% SDS  
 
P3:           3.0M Potassium acetate, pH 5.5  
 
2.2.1.2 Large-scale preparation of plasmid DNA (Qiagen Maxi- Kit) 
A single clone was inoculated in 2 ml LB medium with appropriate antibiotic as a pre-
culture for 8 hrs in 37°C shaker. This pre-culture was added to 100 ml LB medium with 
appropriate antibiotic at a dilution of 1/100 fold and incubated overnight at 37°C with 
shaking. The saturated culture was centrifuged for 15 min, pellet was resuspended in 10 ml 
of solution P1 and cells lysed with P2 and neutralised with P3 as described above. The 
precipitated solution was centrifuged at 10,000 rpm for 30 min at 4°C. Meanwhile, the 
column (Qiagen-tip) that was provided with the Maxi preparation kit was equilibrated with 
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10 ml of QBT solution. After centrifugation the lysate was poured into this equilibrated 
column thus allowing the DNA to bind with the resin present in the bed of the column. The 
column was then washed twice with 30 ml of solution QC. Finally, the DNA was eluted 
with 15 ml of QF solution. To precipitate the DNA, 10.5 ml of isopropanol was added and 
mixed thoroughly and centrifuged at 14,000 x g for 30 min at 4°C. The DNA pellet was 
washed with 70% ethanol and dissolved in 200 µl of TE or DNA grade H2O.  
 
QBT:           750 mM Sodium chloride  
           50 mM MOPS (pH 7.0)  
           15 % Ethanol  
           0.5 % Triton X-100  
 
QC:           1 mM Sodium chloride  
           50 mM MOPS (pH 7.0)  
           15 % Ethanol  
 
QF:           1.25 M Sodium chloride  
           50 mM Tris/HCl (pH 8.5)  
 
2.2.2 Gel electrophoresis  
Gel electrophoresis is the technique by which mixture of charged macromolecules, 
especially nucleic acids and proteins are separated in an electrical field according to their 
mobility which is directly proportional to macromolecule’s charge to mass ratio. 
 
2.2.2.1 Agarose gel electrophoresis of DNA 
Agarose gels are used to electrophoresis nucleic acid molecules from as small as 50 bases 
to more than 50 kilobases, depending on the concentration of the agarose and the precise 
nature of the applied electrical field (constant or pulse). Usually, 1 g of agarose was added 
in 100 ml 1.0 x of TBE buffer, and boiled in the microwave to dissolve the agarose, then 
cooled down to about 60°C before adding ethidium bromide (10 mg/ml). This 1% agarose 
gel was poured into a horizontal gel chamber. 
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2.2.3 Isolation of DNA fragments after agarose gel electrophoresis  
2.2.3.1 QIA quick gel extraction method  
This method is designed to extract and purify DNA of 70 bp to 10 kilobase pair (kb) in 
length from agarose gels. Up to 400 mg agarose can be processed per spin column. The 
principle of this method depends on selective binding of DNA to uniquely designed silica-
gel membrane. To the excised DNA fragment from agarose, gel slice was weighed and 
three volumes of QG buffer was added and incubated at 50°C for 10-15 min. After the gel 
slice was dissolved completely, equal amount of isopropanol was added and mixed well 
and then it was applied over a QIAquick column and centrifuged for 1 min. The flow 
through was discarded and the column was washed with 750 µl of PE buffer. After drying 
the column it was placed into a fresh microcentrifuge tube. To elute DNA, 35-50µl of EB 
buffer was applied to the centre of the QIAquick membrane and centrifuged for 1 min. 
2.2.4 Restriction enzyme digestion of DNA  
Restriction enzyme digestions were performed by incubating double-stranded DNA with an 
appropriate amount of restriction enzyme in its respective buffer as recommended by the 
supplier, and at the optimal temperature for that specific enzyme. Standard digestion 
included 2-10 U of enzyme per microgram of DNA. These reactions were usually incubated 
for 1-3 hrs to ensure complete digestion at the optimal temperature for enzyme activity, 
which was typically 37°C. However for genomic DNA digestion the reaction solution was 
incubated overnight at 37°C. 
2.2.5 Ligation of DNA fragment  
The ligation of an insert DNA into a vector (digested with appropriate restriction enzyme) 
carried out in the following reaction mixture: 
30 ng           vector DNA (digested)  
50-100 ng          DNA (1:3, vector: insert ratio)  
1µl            ligation buffer (10x)  
1µl           T4 DNA ligase (5 U/µl)  
           make a total volume of 10 µl  
Blunt-end ligations were carried out at 16°C overnight, whereas sticky-end ligations were 
carried out at room temperature for 2-4 hrs. 
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2.2.6 E. coli transformation of bacteria 
In order to obtain plasmid DNA for purposes of transfection, sequencing and generating 
probes, the ligation was transformed into a clone of DH5α ™ bacterial cells. The competent 
cells were removed from a –70°C freezer and thawed on ice. Two microlitre of β-
mercaptoethanol and 2 µl of the ligation reaction were added into 100 µl cells aliquot. The 
tube was gently tapped to mix and then incubated on ice for 30 min. To heat shock the cells 
after the incubation, the sample was placed in a 37°C water bath for 45-60 sec, and then 
placed on ice for two minutes. After that 450 µl of LB medium was added, and incubate for 
1 hour at 37°C while shaking at 225 rpm. A 1:10 dilution of the sample was made and 100 
µl of the dilution was plated out on LB agar growth plates containing appropriate 
antibiotics. The plate was incubated in a bacterial cell incubator at 37°C overnight. 
Transformed bacteria form a single colony growth on the appropriate antibiotic selective 
medium. The growth plates were stored at 4°C. 
 
2.2.7 Polymerase chain reaction (PCR) 
PCR is a very sensitive and powerful technique (Saiki et al. 1988) that is widely used for 
the exponential amplification of specific DNA sequences in vitro by using sequence 
specific synthetic oligonucleotides (primers). The general principle of PCR starts from a 
pair of oligonucleotide primers that are designed so that a sense primer directs the synthesis 
of DNA towards an antisense primer, and vice versa. During the PCR, the Taq DNA 
polymerase (a heat stable polymerase) (Chien et al. 1976) catalyses the synthesis of a new 
DNA strand that is complementary to a template DNA from the 5’ to 3’ direction by a 
primer extension reaction, resulting in the production of the DNA region flanked by the two 
primers. It allows the rapid and unlimited amplification of specific nucleic acid sequences 
that may be present at very low concentrations in very complex mixtures. The amplification 
cycles were performed in an automatic thermocycler. The PCR reaction contains in general, 
the following substances: 
   Materials and Methods 
- 35 - 
10 ng          DNA  
1µl           forward primer (10 pmol/µl) 
1µl           reverse primer (10 pmol/µl) 
1µl           10 mM dNTPs  
5µl           10x PCR buffer  
1.5µl          50 mM MgCl2  
0.5µl          Taq DNA Polymerase (5U/µl)  
Up to 50 µl         H2O  
The reaction mixture was placed in a 200 µl reaction tube and placed in thermocycler. A 
standard PCR program is shown here:  
Initial denaturation        95°C for 5 min  
Elongation          95°C for 30 sec (denaturation)  
30-35 cycles         58°C for 45 sec (annealing)  
    72°C for 1-2 min (extension)  
Final extension         72°C for 10 min  
 
2.2.8 DNA sequencing (Sanger et al. 1977) 
In order to verify clones for the presence of any point mutations, appropriate DNA 
preparations were sequenced. Clean plamids were prepared using the Nucleospin plasmid 
prep kit or QIA plasmid prep kit. The purity and concentrations were analyzed 
spectroscopically using DNS method. For a sequencing PCR reaction, plasmid 
concentrations 100 ng/kb were used in a reaction mix of 10 µl which contained 10 pmol 
primer and 2 µl of termination mix (ABI). A standardized PCR reaction program was used 
with an initial denaturation at 95°C for 60 sec, 30 cycles of denaturation at 95°C for 10 sec, 
primer annealing at Tm-2°C for 5 sec, extension at 60°C for 1 min, and terminated with 
60°C for 5 min to facilitate the completion of extension reaction. After PCR completion, 
the products were purified by precipitating with and 75% isopropanol, then the pellet was 
washed with 70% ethanol. The sample was denatured at 90°C for 2 min and resuspended in 
15 µl High Dye formamide before subjecting to analysis by the ABI 310 sequence analyzer. 
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2.2.9 Site-directed mutagenesis  
In vitro site-directed mutagenesis is a valuable technique for studying protein structure-
function relationships. This procedure utilizes a vector carrying the gene to be modified and 
two complementary primers carrying the desired point mutation. These two complementary 
primers were designed such that the mutation region is located at the centre: (15-18 bp)-
(mutation region)-(15-18 bp). The primers each complementary to opposite strands of the 
vector, are extended in the PCR reaction with a turbo pfu polymerase. The PCR reaction 
was carried out in a reaction volume of 50 µl containing 1 µl of the plasmid (from standard 
plasmid prep). 
 
 
 
The PCR reaction allows for the incorporation of the primers which results in a mutated 
plasmid with staggered nicks. In order to remove the parental vector the reaction was 
digested with DpnI for 2-3 hours. DpnI endonuclease is specific for methylated and 
hemimethylated DNA which is the case only for the parental vectors. The product was then 
purified through the column and used for transformation in E.coli. The presence of 
mutations was confirmed by sequencing the plasmids after their isolation from the 
transformants. 
To mutate TWISTNLS1 and TWISTNLS2 the Quick changeM site directed mutagenesis kit 
(Stratagene) was used. Therefore, about 30 bp long primers were designed (Table 4), which 
contained the desired mutation and annealed at the same sequence on the opposite strands 
of the plasmid. The reactions were prepared as followed. 
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5 µl          10 x Pfu Ultra reaction buffer  
50 ng          template DNA  
10 pmol         each primer  
1 µl          dNTP mix (25 mM each dNTP)  
2.5 U          Pfu Ultra 
5.0 µl          DMSO  
dd H2O to final volume of     50 µl  
The reaction was cycled using the following parameters.  
1. Denaturing:        95 °C for 30 sec  
2. Denaturing:        95 °C for 30 sec  
3. Annealing:        55 °C for 1min  
4. Polymerization:       68 °C for 1 min per kb of plasmid length 
Step 2 to 4 was cycled 12 times. The PCR was treated with 10U of DpnI restriction enzyme 
for digestion of the PCR product to remove the methylated parental DNA. 
 
2.3 Cell biology methods 
2.3.1 Culture of human cells 
Handling and propagation of all cell lines were performed in a cell and tissue culture 
laminar-air flow under aseptic conditions. All solutions were stored at 4°C and warmed up 
to 37°C in a water bath before using. All solutions were only opened under aseptic 
conditions in a laminar flow. The adherent U2-OS (Osteosarcoma ) cells were grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10 % FCS, 5% non essential 
amino acids and 5% penicillin/streptomycin in the incubator at 37° C, 5% CO2 and 88% 
moisture. 
 
2.3.2 Freezing cultured human cells 
To freeze cells for long term storage, cells were harvested (at least one T75 flask of 80 % 
confluent cells) and centrifuged at 1,000 x g for 5 min. The media was then aspirated and 
cells were resuspended in 1 ml of cell culture freezing medium. The resuspended cell 
solution was transferred to cryo-vials and kept at –70° C in an isopropanol-containing cell 
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freezing container, which guarantees a slow freezing process. After 24 hrs the tube can be 
stored at –70°C or in liquid nitrogen in a tube. 
 
2.3.3 Splitting the human cells 
All cell lines were grown in a 37°C incubator and split in certain ratios depending on the 
stage of confluence and the proliferation rate of each cell line. The amount of medium 
added to the flask was dependent on its size. After that 10 ml were added into medium 
sized flasks (T75). The medium was changed every second day. 1/10 of the amount of 
culture medium was used as amount of trypsin/EDTA supplied to a culture flask in order to 
detach the cells. To split cells the medium was completely aspirated from the flask and the 
cells were washed briefly with 1 ml of trypsin to remove traces of antitrypsin originating 
from the serum in the media. The cells detached after about 5 min upon occasional gentle 
tapping. Trypsin was then immediately inactivated by adding 3 ml of medium to each flask. 
This suspension was transferred into a 15 ml tube and centrifuged at 1,000 x g for 5 min. 
The supernatant was aspirated and the cell pellet was resuspended in medium and split into 
3 to 5 new flasks. For each experiment, each individual cell line was pooled during the 
splitting process to assure equal amounts of cells plated into each flask.  
 
2.3.4 Maintenance of human cell lines 
The cell line aliquots were stored in 1 ml freezing medium at -80°C. Cell lines were grown 
by quickly thawing the frozen cells in a 37° C water-bath then transferring them into a 15 
ml tube to be mixed with 10 ml of medium. The suspended cells were centrifuged at 1,000 
x g for 5 min. in order to isolate a cell pellet free of DMSO residues from the freezing 
medium. After removing the supernatant the pellet was resuspended in 10 ml medium and 
transferred into a cell culture flask. The cells were incubated at 37°C with 5% CO2. 
 
2.3.5 Transient transfection of mammalian adherent cells 
In this study the QIAGEN effectene transfections reagent was used for transferring foreign 
DNA into mammalian cells. Effectene Transfection Reagent is an innovative non-liposomal 
lipid formulation used in conjunction with a special DNA-condensing enhancer and 
optimized buffer to achieve high transfection efficiencies. The enhancer first condenses the 
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DNA molecules and effectene reagent subsequently coats them with cationic lipids 
providing a particularly efficient way of transferring DNA into eukaryotic cells.  Effectene 
Reagent is used in conjunction with the enhancer and the DNA-condensation buffer (Buffer 
EC) to achieve high transfection efficiencies. In the first step of effectene–DNA complex 
formation, the DNA is condensed by interaction with the enhancer in a defined buffer 
system. Effectene reagent is then added to the condensed DNA to produce condensed 
effectene–DNA complexes. The Effectene–DNA complexes are mixed with medium and 
directly added to the cells. Effectene transfection reagent spontaneously forms micelle 
structures that show no size or batch variation, as found with preformulated liposome 
reagents. This unique feature ensures excellent reproducibility of transfection complex 
formation. The process of highly condensing DNA molecules and then coating them with 
effectene reagent is a particularly effective way to transfer DNA into eukaryotic cells. 
 
2.3.6 Cell density at the time of complex addition 
Table 11 lists the recommended number of adherent cells to seed per culture plate/dish the 
day before transfection, and the recommended number of suspension cells to seed the 
volume of medium to use the day of transfection. For adherent cells, the optimal confluency 
at the time of transfection complex addition is normally 40–80%. 
 
Table 11: Recommended number of cells per culture vessel for transfection assay 
 
Assay Sowing cells 
numbers 
Amount 
of DNA 
Enhancer EC 
Buffer 
Effectene Medium 
RT-PCR 8x105 cells 
per 56 cm2 
1–2 µg 10 µl 250 µl 12 µl 2 ml 
Immuno-
fluorescence 
1.5x105 cells 
per 10 cm2 
400 ng 3.2 µl 100 µl 4 µl 600 µl 
SDS-PAGE, 
Western blot 
1x106 cells 
per 74 cm² 
2–3µg 14 µl 400 µl 16 µl 4 ml 
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2.3.7 Isolation of total RNA from the human cells 
Total RNA from cells was isolated by following the manufacturer’s protocol describing the 
application of the Qiagen RNeasy mini kit. The concentration and purity of RNA was 
determined by measuring the absorbance at 260 nm (A260) in an UV/VIS 
spectrophotometer and by visual inspection of the preparation on an Rnase free agarose gel 
to exclude degradation. Absorbance 1 at A260 corresponds to a RNA concentration of 
40µg/ml such that the RNA concentration is given by: 
 
Where [RNA] is the RNA concentration in µg/ml and a, the absorbance measured at 260 
nm. 
 
2.3.8 Reverse transcription PCR (RT-PCR) 
RT-PCR generates cDNA fragments from RNA templates. In an autoclaved tube the total 
RNA was mixed with 1 µl random hexamer primer (concentration) and 1 µl dNTPs 
(concentration) in a total volume of 10 µl. To avoid the possible secondary structure of the 
RNA, which might interfere with the synthesis, the mixture was heated 65°C for 5 min, and 
then quickly chilled on ice. After a brief centrifugation, 9 µl of master mix prepared from 
the following reagents was added. 
2 µl            10X RT Buffer 
4 µl            25 mM MgCl2 
2 µl            0.1 mM DTT 
1 µl           RNase inhibitor 
 
The content of the tube was mixed gently and incubated at 25°C for 2 min.One microlitre 
of reverse transcriptase enzyme (Superscript II) was then added, and further incubated at 
25°C for 10 min, then 42°C for 50 min and 70°C for 15 min for the first strand cDNA 
synthesis. Afterthat, 1 µl of RnaseI added and again incubated for 20 min. The synthesized 
cDNA was store at –20°C for further use. One microlitre of the first strand reaction was 
used for the PCR reaction (as described above). 
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2.3.9 Immunofluorescence and microscopy 
2.3.9.1 Paraformaldehyde fixation  
Cells grown in slide chamber were washed twice in 1X PBS and fixed with 4% 
paraformaldehyde in PBS for 20 min at room temperature. After rinsing the slides once in 
PBS, the cells were permeabilized in 0.2% Triton X-100 in PBS for 5 min at room 
temperature. The slides were again rinsed twice in PBS and then incubated in PBS for 5 
min. The cells were blocked in 10% BSA in PBS for 30 min at RT or over night at 4°C. 
 
2.3.9.2 Staining and microscopy 
Fixed cells were incubated with a primary antibody, diluted in 1% BSA/PBS-Tween 20 
from 1:200 cover over the slide and incubate for 1 h at 37°C. The slides were washed three 
times for 5 min in 0.5% Tween-20 in PBS and stained with a secondary antibody 
conjugated with Texas red in a 1:1000 dilution in 1% BSA in PBS for 1 h at 37 °C. The 
slides were washed again three times for 5 min in 0.5% Tween-20 in PBS. To stain the 
nucleus, 1 µg DAPI was added to the 50 ml PBS. After 3 min incubation the slides in 
DAPI, were again washed three times in 0.5% Tween-20/PBS and mounted using mounting 
media (Vectorshield). The slides were sealed with the mounting medium and the cells were 
analyzed using an Axiovert 135 microscope (Zeiss) with 40X objective (Zeiss) with a 
numeric aperture of 1.3. The pictures were taken with a CCD-camera and saved with 
metaview software. Further preparation of the pictures was performed with Adobe 
Photoshop. 
 
2.4 Techniques related to protein 
2.4.1 Preparation of protein extract 
For the preparation of protein extracts from cell lysates, cell density was monitored 
spectroscopically at 600 nm (OD600nm), culture volumes corresponding to OD600nm values 
of 5 or 10 were harvested, and cells were isolated by centrifugation at 4°C. This procedure 
ensured that comparable amounts of cells were withdrawn for protein extract preparation 
even when cells of different growth stages had to be compared. The isolated cell pellets 
were lysed by lysozyme treatment. For cell lysis by lysozyme treatment, the cell pellet was 
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resuspended in a lysis buffer (50 mM EDTA, 0.1 M NaCl, pH 7.5) containing 50 µg/ml of 
lysozyme and incubated for 10-15 min at 37°C until the dense solution started clearing. 
Independent of the cell lysis method applied, the cell lysates were centrifuged to remove 
the cell debris. An aliquot of each lysate was stored at -20°C for future use and 100 µl of 
the lysates were boiled with the denaturing protein loading buffer and equal volumes of 
these samples were loaded on a SDS gel for inspection of whether the protein contents were 
of comparable concentration. 
 
2.4.2 Separation of proteins by SDS-polyacrylamide gel electrophoresis (Laemmli 
1970) 
The protein sample to be resolved was denatured by heating at 95°C for 2 min in the 
presence of SDS and β-mercaptoethanol (see protein loading buffer composition below). 
While β-mercaptoethanol reduces disulfide bonds, SDS denatures and anneals to the amino 
acid chains of the proteins giving each protein a negative net charge proportional to the 
polypeptide chain length. As a consequence, the proteins are separated essentially based on 
their molecular mass (Laemmli, 1970). The sieving effect of the gel matrix is achieved by 
adjusting an appropriate ratio of acrylamide to N, N’ methylene bisacrylamide (37.5/1).The 
polymerization of acrylamide is catalyzed by adding 0.1% APS (w/v) and 0.05% TEMED 
just before pouring into the casket. The migration of the proteins was carried out in running 
buffer under a constant current of 25 mA for 2 h. 
Loading buffer:  
100 mM          Tris/HCl, pH 6.8 
10%           (v/v) glycerol 
2.0%           (w/v) SDS 
3.0%           (v/v) β-mercaptoethanol 
0.1%           (w/v) bromophenol blue 
Running buffer: 
25 mM           Tris/HCl, pH 8.3 
250 mM          Glycine 
0.1%           (w/v) SDS 
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2.4.3 Protein staining with coomassie blue 
After electrophoresis, the proteins in the gel were fixed and stained in staining solution with 
gentle agitation for 1-2 hours. In order to remove non-specific dye from the protein gels, 
the gel was destained in the destaining solution. 
Staining solution: 
0.125%          (w/v) Coomassie blue 
10%           (v/v) acetic acid 
25%           (v/v) ethanol 
Destaining solution: 
10%           (v/v) acetic acid 
20%           (v/v) ethanol 
 
2.4.4 Determination of protein concentration (Bradford 1976) 
To determine the protein concentration, Bio-Rad protein assay based on the differential 
colour change of a dye in response to various concentrations of protein was used. The assay 
is based on the observation that the absorbance maximum for an acidic solution of 
Coomasie Blue G-250 shifts from 494 to 595 nm when the binding to protein occurs. The 
BSA stock solution of 1 mg/ml was diluted in order to obtain standard dilutions in range of 
10 µg/ml-100 µg/ml. The Bio-Rad’s colour reagent was diluted 1:5 with H2O, and filtered 
through 0.45 µm filters. In a 96 well microtiter plate, 20 µl of each standard dilution and 
the samples to be measured were pipetted with 280 µl of the color reagent. The absorption 
of the colour reaction was measured at 595 nm in spectrophotometer (Bio-Rad). 
 
2.4.5 Western blotting 
For the detection of specific proteins on protein gels, a technique termed western blot was 
applied in which the protein bands were first transfered to a polyvinylidene fluoride 
(PVDF) 0.45 µm microporous membrane (Immobilon-P, Millipore). An air bubble-free 
sandwich was formed from Whatman 3MM filter papers embedding the membrane and the 
gel. All components were pre-soaked in transfer buffer and the electro transfer was carried 
out in a semi dry transfer system (Bio-rad) for 90 minutes under a constant current 
calculated by the area of the gel (in cm) multiplied by 0.8 mA. After transfer, the proteins 
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were visualized by staining the membrane with amido black solution for 1-2 minutes and 
destaining with dH2O. 
Transfer buffer: 
48 mM           Tris base 
39 mM           glycine 
1.3 mM          SDS 
20%           methanol 
 
2.4.6 Immunodetection 
After transferring the proteins to a PVDF membrane, the non-specific sites were blocked by 
incubating the membrane in blocking buffer for 30 min at RT. The membrane was then 
incubated in blocking buffer with a defined dilution of the primary antibodies (see below) 
overnight at 4°C or for 1 h at 37°C. The membrane was washed to eliminate the unbound 
antibodies, once for 10 minutes and twice for 5 min with PBS-T at RT. The membrane was 
then incubated in blocking buffer with the secondary antibody coupled to horseradish 
peroxidase (1:10000 dilutions of antirabbit or 1:5000 of anti-mouse) for 1 h at 37°C. The 
membrane was washed again as described earlier to eliminate the unbound secondary 
antibodies. The proteins recognized by the primary antibodies were detected using ECL 
(enhanced chemiluminescence). 
PBS-T:          80 mM Na2HPO4 
           20 mM NaH2PO4 
           100 mM NaCl, pH 7.5 
           0.2% (v/v) Tween-20 
 
 
2.5 Yeast-two-hybrid system 
Yeast-two-Hybrid System is a complete GAL4-based two-hybrid system providing a 
transcriptional assay for detecting specific protein-protein interactions in yeast. The 
MATCHMAKER yeast-two-hybrid systems can be used either to screen a library for a 
gene encoding a novel protein that interacts with a known bait protein or to test two 
previously cloned proteins for interaction. 
   Materials and Methods 
- 45 - 
The yeast two-hybrid assay is based on the fact that many eukaryotic trans-acting 
transcription factors are composed of physically separable, functionally independent 
domains. Such regulators often contain a DNA-binding domain (DNA-BD) that binds to a 
specific enhancer-like sequence, which in yeast is referred to as an upstream activation site 
(UAS; Heslot and Gaillardin 1992). One or more activation domains (AD) direct the RNA 
polymerase II complex to transcribe the gene downstream of the UAS (Keegan et al. 1986; 
Hope and Struhl 1986; Ma and Ptashne 1987). Both the DNA-BD and the AD are required 
to activate a gene and normally, as in the case of the native yeast GAL4 protein, the two 
domains are part of the same protein. If physically separated by recombinant DNA 
technology and expressed in the same host cell, the DNA-BD and AD peptides do not 
directly interact with each other and thus cannot activate the responsive genes (Brent and 
Ptashne 1985; Ma and Ptashne 1988). However, if the DNA-BD and AD can be brought 
into close physical proximity in the promoter region, the transcriptional activation function 
will be restored. In principle, any AD can be paired with any DNA-BD to activate 
transcription, with the DNA- BD providing the promoter specificity (Brent and Ptashne 
1985). 
 
2.5.1 Vectors used in yeast-two-hybrid assay 
In the MATCHMAKER Two-Hybrid system, the DNA-BD and the AD are both derived 
from the yeast GAL4 protein (aminoacids 1–147 and 768–881, respectively). Two different 
cloning vectors are used to generate fusions of these domains to genes encoding proteins 
that potentially interact with each other. The recombinant hybrid proteins are coexpressed 
in yeast and are targeted to the yeast nucleus (Chien et al. 1991). An interaction between a 
bait protein (fused to the DNA-BD) and a library encoded protein (fused to the AD) creates 
a novel transcriptional activator with binding affinity for a GAL4-responsive UAS (Fig. 6). 
This factor then activates reporter genes having upstream GAL4- responsive elements in 
their promoter and this makes the protein-protein interaction phenotypically detectable. 
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Fig. 6: The yeast two hybrid bait pGBKT7 and library pGADT7 cloning vectors. The entire TWIST, 
NSEEE, and WR were cloned into the MCS of pGBKT7 vector and pGADT7 are expressed as fusion to the 
GAL4 binding domain (DNA-BD) and a activation domain (AD9, respectively). Interaction of both proteins 
allows activation of a down stream reporter. 
 
2.5.2 Transformation of bait plasmid in yeast S. cerevisiae AH109  
In this study we used yeast S. cerevisiae AH109 strain. The bait plasmids were transformed 
in the commercially available AH109 chemical competetent cells. One vial of frozen cells 
from –70°C was used and thawed at RT. In a sterile 1.5 ml prechilled tube, 400 ng bait 
plasmid and 200 µl competent yeast cells were combined and gently mixed by pipetting. 
1.2 ml PEG/LiAC solution was then added and the mixture vortexed for 3-5 sec. The tube 
was incubated at 30°C for 45 min, with vortexing every 10 min and then at 42°C in a water 
bath for 15 min. After 15 min the yeast cell was centrifuged at 700 x g for 5 min, the 
supernatant discarded and the cells resuspended in 0.25 ml recovery medium. The cells 
then incubated again 30°C for 90 min. The yeast cells were centrifuged and the supernatant 
discarded, the pellets were resuspended in 0.5 ml TE and plated out on to the QDO–Trp 
plates and then incubated at 30°C for one week. 
 
2.5.3 Yeast mating 
Yeast mating is a convenient method of introducing two different plasmids into the same 
host cells (Harper et al. 1993; Finley and Brent 1994). One colony of each type picked to 
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use in the mating. Only large (2–3 mm), fresh (<2-months old) colony from the working 
stock plates were used, and each colony placed in a 1.5 ml microcentrifuge tube containing 
0.5 ml of YPD medium. The tubes were vortexed to completely resuspend the cells. A 
concentrated overnight culture of the bait strain was prepared (i.e. AH109 [bait]) as 
follows: 
One large (2–3 mm), fresh (<2 months old) colony of AH109 [bait] was inoculated into 50 
ml of SD/–Trp, and incubated overnight (16–24 hrs) at 30°C with shaking at 250–270 rpm. 
The entire AH109 [bait] culture and the 1 ml library culture was combined in a 2 L sterile 
flask, and 45 ml of 2X YPDA/Kanamycin added and gently swirled. Two aliquots of 1 ml 
of 2X YPDA/Kanamycin was used to rinse cells from the library tube followed by 
incubation at 30°C overnight (20–24 hrs) with gentle swirling (30–50 rpm). The mating 
mixture was then transfered into a sterile centrifuge bottle and the cells spun down by 
centrifuging at 1,000 x g for 10 min. Meanwhile, the mating flask was rinsed twice with 2X 
YPDA/Kanamycin (50 ml each rinse), the rinses combined and used to resuspend the first 
pellet. The cells again spun down at 1,000 x g for 10 min, the cell pellet resuspended in 10 
ml of 0.5X YPDA/Kanamycin, and the total volume of cells measured in YPDA medium. 
The library mating mixtures were plated as follows: 100 µl of a 1:10,000, 1:1,000, 1:100, 
and 1:10 dilution of the mating mixture was spread on SD/–Leu, SD/–Trp, and SD/–Leu/–
Trp plates for mating efficiency controls (90 mm plates). The remaining mating mixture 
was spread on ~50 large (150 mm) plates, at 200 µl per plate, equivalent to ~ 2 x 104–2 x 
105 cells per plate. 
Important Notes: 
• The flask size must be at least 2 L to permit sufficient aeration of the mating culture at 
low-speed swirling. 
• Low-speed swirling is necessary to keep cells from settling to the bottom of the flask. 
Shaking the culture at speeds >50 rpm will significantly reduce mating efficiency. 
 
2.5.4 Plasmid isolation from yeast 
A large 2–4 mm, from 2-4 days old yeast colony was used to inoculate a 0.5 ml of the 
appropriate SD liquid medium. The tube was vortexed vigorously to completely resuspend 
the cells. 10 ml of lyticase solution was then added to each tube, and  the cells resuspended 
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thoroughly by vortexing or repeatedly pipetting up and down, followed by incubation at 
37°C for 30–60 min with shaking at 200-250 rpm. After that 10 ml of 20% SDS was added 
to each tube and the tubes vortexed vigorously for 1 min to mix. The samples were 
subjected through one freeze/thaw cycle (at –20°C) and vortexed again to ensure complete 
cell lysis. The volume of the sample was brought up to 200 ml in TE buffer (pH 7.0), and 
200 ml of phenol: chloroform: isoamyl alcohol (25:24:1) added, followed by vortexing at 
maximum speed for 1 min. After centrifugation at 14,000 rpm for 10 min, the aqueous 
(upper) phase was transferred to a fresh tube, and then 8 µl of 10M ammonium acetate and 
500 µl of 95–100% ethanol were added. The suspension was incubated at –70°C or in a 
dry-ice/ethanol bath for 1 h, and then centrifuged at 14,000 rpm for 10 min. The 
supernatant was discarded and the pellet dried prior to pellet resuspension in 20 µl of H2O 
 
2.5.5 PCR amplification from yeast 
The amplification cycles were performed in an automatic thermocycler. The PCR reaction 
contains in general, the following substances:  
1 µl           Yeast plasmid 
1 µl          5 LD Inscr primer (10 pmol) 
1 µl           3 LD Inscr primer (10pmol) 
2.5 µl           10x Buffer 
0.125 µl          dNTPSs 
1 µl           MgCl2 
0.125 µl          Taq polymerase (units/ml) 
up to 25 µl          H2O 
The reaction mixture was prepared in a 200 µl reaction tube and reaction was carried out in 
a thermocycler. A standard PCR program is shown here:  
Initial denaturation        95° C for 2 min  
Elongation          95°C for 30 sec (denaturation)  
35 cycles          58°C for 30 sec (annealing)  
    72°C for 4 min (extension)  
Final extension         72°C for 4 min  
Store          4°C 
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3 Results 
TWIST nuclear import mechanism was studied to observe misdistribution of bHLH 
transcriptional factor TWIST in the human cells, particulary when nucleus localization 
signals (NLSs) of TWIST were altered. In order to examine the functionality of N-terminal 
part of bHLH transcriptional factor TWIST, we comapred different Twist proteins sequences 
using the PROSITE program and predicted that two highly conserved nucleus localization 
signals (NLS1 and NLS2) present at amino acid positions 37-40 and 73–77, respectively in 
the N-terminal part of the TWIST protein. NLSs are generally rich in the basic amino acids 
lysine or arginine, and responsible for the ability of proteins to translocate from the 
cytoplasmic compartment of the cell to the nucleus. 
 
3.1 Selection of human cell line 
The importance of bHLH transcription factor TWIST is well established in osteogenesis 
and suggests that its expression preventing premature or ectopic osteoblast differentiation. 
Therefore, it is important to select a human cell line originated from the mesoderm and in 
which TWIST is expressed endogenously. Furthermore, to select a human cell line several 
factors were considered such as constant growth conditions, proliferate steadily and easy to 
transfect. Considering all these factors alltogether, several cell lines were tested like OHS, 
CCL-136, COS7, and U2-OS. Finally, U2-OS (Osteosarcoma) cell line was selected for 
further experiments. The U2-OS cell is originated from the mesoderm and in which TWIST 
was expressed endogenously, which is important for the nucleus import mechanism. 
 
3.2 Confirmation of endogenous expression of TWIST in U2-OS cells by RT-PCR 
RT-PCR was performed to examine the endogenous expression of TWIST in U2-OS cells. 
The cDNA was synthesized using the Oligo (dT) primers from total RNA isolated from 
U2-OS cells and TWIST expression was detected in cDNA using the TWIST specific 
oligonucleotides TWIST f/r. 
To exclude the possible contamination of genomic DNA in cDNA synthesis, GAPDH gene 
was used as a positive control, which is ubiquitously expressed for the glyceraldehyde-3-
phosphate dehydrogenase. The GAPDH-f and GAPDH-r primers were selected in such a 
way that it spans an intron of the GAPDH gene. Due to different product sizes, it could be 
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differentiated between genomic DNA and cDNA amplification. All blank PCRs were done 
with the help of (-) RT control for genomic impurities examination (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: The endogenous expression of TWIST in the U2-OS cell line.  Detection of coding region of 
TWIST in the U2-OS cells using Twist-f and Twist-r primers: (M) 100 bp size standard DNA ladder; (1) 
negative control without reverse transcriptase to exclude the contamination by genomic DNA; (2) (+) 630 bp 
fragments containing coding region of TWIST (3) (-) negative control for RT PCR GAPDH; (4) (+) RT PCR 
GAPDH used as positive control. 
 
3.3 Generation of TWIST fusion constructs  
3.3.1 Generation of TWIST fusion constructs with c-myc epitope 
TWIST fusion construct with c-myc epitope was prepared to analyze the functionality and 
subcellular localization using indirect immunofluorescence assay. TWIST cDNA was 
cleaved by XhoI and EcoRI from the pBluescript II KS Phagemid vector. The cleaved 
cDNA was cloned into PCMV vector at the 5'-over-hanging end. The pCMV-tag 
expression vector is derived from the pCMV-script vector which contains sequences for c-
myc epitope at either N or C- terminal. The c-myc epitope tag is small, highly 
immunoreactive, not likely to interfere with the function of the target protein, and allow 
easy purification and detection of the fusion protein by using anti c-myc antibodies. The c-
myc epitope is derived from the human c-myc gene and contain 10 amino acid residues 
(EQKLISEEDL). In addition to the epitope tag sequences, the pCMV-tag vector contains 
features for expression of the fusion proteins in eukaryotic cells. 
M 1 2 3 4
600 bp  
300 bp 
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A 6 to 8 bp long oligonucleotide was created, which contains BamHI restriction 
endonuclease site. A complementary strand of DNA was synthesized using the Klenow 
using one simply mixed single-stranded template, primers and the enzyme with an 
appropriate buffer for the creation of BamHI restriction sites at both ends. After ligation, 
TWIST was fused with c-myc epitope at N-terminal site (Fig. 8).  
 
 
Fig. 8: Schematic representation the construction of fusions protein TWIST cDNA~c-mycN. This figure 
represents the fusion of 202 amino acid wide TWIST and 10 amino acid long c-myc epitopes. In this construct 
the TWIST cDNA is cloned in pCMV mammalian expression vector which consists of c-myc epitope on N-
terminal. 
 
3.3.2 Cloning of E12 ORF into the pEGFP-N1 vector 
Class B bHLH proteins to which H-TWIST belongs are known to form stable heterodimers 
with members of class-A bHLH transcription factors including E12 and E2-2 (Murre et al. 
1989b; Henthorn et al. 1990). The E12 cDNA was cloned into pSP65 vector which was 
received from Christian Kosan. The E12 open reading frame was amplified by the PCR and 
cloned into Topo TA cloning vector. The E12 ORF was then released from the Topo vector 
by EcoRI digestion. After purification, the insert was ligated into the EcoRI sites of the 
multiple cloning site of the mammalian expression vector pEGFP-N1 (Fig 9). 
 
 
 
 
 
 
 
Wild type-TWIST-cDNA c-myc
5‘ 3‘ 
pCMV-Tag3C 10 aa 202 aa 
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Fig. 9: Schematic representation of E12-pEGFPN1 fusion construct. This figure represents the fusion of 
648 amino acids wide E12 ORF tagged with GFP. In this construct the E12 is cloned in eGFPN1 mammalian 
expression vector which consists of GFP on C-terminal. 
 
3.3.3 Generation of mutations in TWIST by site directed mutagenesis  
The active transport of proteins in both directions across the nuclear envelope requires the 
presence of specific targeting sequences within the protein (Görlich and Mattaj 1996). To 
determine the key role of the NLS in the TWIST protein transport,  the basic amino acid 
residues of the two putative nucleus localization signals were substituted at the position 37-
40 (RKRR, NLS1) and 73-77 (KRGKK, NLS2) using site directed mutagenesis (Table 12). 
Specifically, to test the functionality of these two motifs, each of these basic amino acid 
residue were systematically altered individually or in combination with others in the first 
NLS cluster K38R and the effect of these mutations on nucleus localization of TWIST 
protein in transiently transfected U2-OS cells were assayed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GFP E12 ORF
3‘ 5‘ 
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Table 12: Wild type and mutated amino acid sequences of TWIST nuclear localization 
signals 
 
Clone Name NLS1 NLS2 
NLS1wt RKRR KRGKK 
K38R RRRR KRGKK 
K73R RKRR RRGKK 
K77R RKRR KRGKR 
K76R RKRR KRGRK 
K38R / K73R RRRR RRGKK 
K38R / K76R RRRR KRGRK 
K38R / K77R RRRR KRGKR 
The mutated amino acids are bold and underlined. 
 
3.4 Expression control of the fusion constructs in transient transfected U2-OS cells 
The expression of pCMV-TWIST fusion construct in U2-OS cells was analysed using RT-
PCR and Western blot analysis. The primers were designed to amplify the target sequence 
in such a way that PCMV3C/twist f is located in the c-myc coding sequence and 
PCMV3C/twist r hybridize with a part of a TWIST-cDNA fragment (Fig. 10). A 70 bp 
target cDNA was amplified using the insert specific primers which allowed the distinct 
identification of the fusion constructs (Fig. 11). To avoid the contamination of genomic 
DNA a negative RT(–)PCR was used as a negative control. 
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Fig. 10: The position of the used oligonucleotide in RT-PCR. The primer pairs used in RT-PCR for 
expression of fusion construct were created in such a way that one of the primer is located in the c-myc 
coding sequence and other primer hybridize with a part of a Twist-cDNA fragment: The Twist cDNA in 
pCMV Tag3C vector TWISTcDNA~c-mycN and the position of the primer pCMV3C Twist forward and 
reverse is shown. 
 
 
Fig. 11: Expression of TWISTcDNA~c-mycN in transiently transfected U2-OS cells by using RT-PCR. 
M represents the 25 bp ladder; Line 1 and 3 represents represents the amplified TWISTcDNA~c-mycN (70bp) 
pCMVtag 3C vector; Line 2 used as a negative control (-RT) to exclude the genomic contamination. 
 
3.5 Subcellular localization of TWIST protein in an immunofluorescence assay 
The subcellular localization of TWIST constructs into U2-OS cells was determined by an 
indirect immunofluorescence assay. The indirect immune detection of the TWIST c-myc 
fusion protein is undertaken by incubation with a monoclonal antihuman c-myc antibody 
(Molecular probes, Göttingen, Germany) as well as with a Texas Red-coupled anti mouse 
IgG secondary antibody (Molecular Probes). The sub-cellular distribution of the fusion 
Wild type-TWIST-cDNA S c-myc 
5‘ 3‘ 
pCMV-Tag3C 
pCMV3C/twist f pCMV3C/twist r 
BamHI BamHI 
125 bp 
75 bp 
M 1 2 3 
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proteins could be determined accurately by using the cyto skeleton f-actins labelled with 
Alexa fluorine Phalloidine (Molecular Probes) as reference and by staining the cell nucleus 
with DAPI. The different structures were represented both individually and in an overall 
view fluorescence-microscopically, which was possible due to the use of different 
fluorochrome (Materials and Methods 2.1.16: Table 9). 
 
3.5.1 Localization of TWIST cDNA fusion protein into human U2-OS cells 
In order to test the hypothesis that the transcription factor TWIST is actively imported into 
the nucleus, the sub-cellular localization of the TWIST-cDNA~c-mycN fusions proteins was 
determined by an indirect immunfluoresence assay into human U2-OS cells. The fusion 
construct TWISTcDNA~c mycN was introduced into U2-OS cells using various liposomal 
and non-liposomal transfections reagents such as calcium phosphate, LipogenTM, and 
Effectene. Cell mortality and transfection efficiency were monitored by microscopy. The 
non-liposomal transfection reagent Effectene (Qiagen, Germany) was selected due to a 
lower cell mortality and satisfactory transfection efficiency. 
The experimental procedures were optimized in this manner so that the immune colouring 
techniques used to detect the various TWIST c-myc fusion proteins, did not negatively 
affect adherent U2-OS cell morphology. In order to minimize non-specific signals during 
immune detection, different concentrations of the primary as well as the secondary anti-
bodies were optimized and best signals were observed with 1:700 and 1:10,000 dilutions 
for anti- human c-myc antibody (primary antibody) and for anti- mouse IgG~TR antibody 
(secondary antibody), respectively. 
 
3.5.2 Sub-cellular immune localization of TWIST cDNA~cmyc and galactosidase c-
myc fusion constructs in U2-OS cells 
To investigate the 25 kDa human TWIST subcellular localization, TWIST cDNA was fused 
in pCMVc-myc tag vector. Plasmids encoding c-myc-TWIST were transfected into U2-OS 
cells and protein verified using Western blotting. A 28 kDa protein was recognized by an 
anti-c-myc antibody suggesting that it was a fusion of c-myc (3 kDa) with TWIST (Fig. 
12). 
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Fig. 12: Expression of Twist-cmyc fusion construct by western blot analysis using anti-c-myc antibody. 
Line 1 used for a negative control which contains the empty vector pCMV, and line 2 represents a 28 kDa 
fused TWIST-c-myc protein. 
 
No back ground signals were detected in the subcellular localization of c-myc and the 
TWIST-cDNA-c-myc constructs in U2-OS cells using fluorescence microscopy, which 
showed that c-myc itself does not play any role in the U2-OS cells (Fig. 13 Ia-d). The 
fusion protein from β-galactosidase and c-myc epitope should only locate into the 
cytoplasm of eukaryotic cells, due to the high molecular weight of the bacterial metabolic 
enzyme (540 kDa), and missing topogene nucleus localization signals a free passage 
through the nuclear pore complex and an active nuclear import is not possible. The fusion 
protein could be detected, as expected, only in the cytoplasm of human U2-OS cells (Fig. 
13 IIa-d). TWIST-cDNA-c-myc construct was predominantly localized into the nucleus 
(Fig 13 IIIa-d). Position of nucleus was determined using DAPI staining (Fig. 13 III b). 
Merged images summarize the results (Fig. 13 IIIa-d). 
28 kDa 
NC TWIST-cmyc 
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Fig. 13: Subcellular localization of tagged protein. TWIST is fused with c-myc; subcellular localization of 
the fusion construct is monitored following transient transfection in U2-OS cells. (Ia-d) represent the negative 
control in transient transfection (without TWIST); (II a-d) subcellular localization of c-myc~β-galactosidase 
fusion construct distributed in U2-OS cell cytoplasm: (III a-d) show U2-OS cells transiently transfected with 
c-myc~TWIST. The distribution of TWIST fusion protein is limited to the nucleus. (a-d): subcellular immune 
localization of under (a) the Merged picture of the objects are specified, (b) show DAPI Staining for cell 
nucleus; (c) with anti-human the C-myc and the anti- mouse IgG anti-body detected, Texas Red colored 
TWIST C myc Fusions proteine, (d) represents the picture with Alexa fluorine 488 Phalloidin marked cyto 
skeleton f-actins (Oil immersion 100X magnification). 
 
The sub cellular localization of the TWIST~c myc fusion construct and distribution of the 
TWIST mutants had been observed in U2-OS cells with the help of fluorescence-
microscopic analysis. The proteins were either imported completely into the nucleus or held 
back in the cytoplasm completely. 
 
 
 
Ia Ib Ic Id
IIa IIb IIc IId
IIIb IIIc IIId
Overlay DAPI anti-c-myc Phalloidine 
IIIa 
   Results 
- 58 - 
3.6 Subcellular localization of TWIST NLSs mutants 
By the precise localization of the TWIST cDNA~c-myc fusion protein in U2-OS cells, a 
strategy for further analysis was formulated to identify and characterize potential TWIST 
protein nucleus localization signals. The sequence of the core import essential motifs could 
be determined based on the subcellular localization of NLS1 and NLS2 mutants. We 
substituted the lysine to arginine by using site directed mutagenesis as the basic amino acid 
residues form two clusters in H-TWIST (Table 12). One basic amino acid residue was 
mutated into the TWISTNLS1 at the position 38 of this cluster (K38R), and the effect of 
mutated TWISTNLS1 protein for the nucleus localization was evaluated into the transiently 
transfected U2-OS cells. The expression of the altered TWISTNLS1 at the amino acid 
position 38 was observed in the cytoplasm of the U2-OS cells after the 
immunofluorescence assay for which the potential topogene nucleus import signals were 
systematically removed (Fig. 14 Ia-d). 
To understand the role of the second cluster in the nucleus localization of TWISTNLS2, the 
amino acids were substituted at the position 73, 76 and 77, respectively. The subcellular 
distribution of mutant 76 TWISTNLS2 (Fig. 14 IIIa-d) was observed into the nucleus, while 
the subcellular distribution of the mutants 73 and 77 was accumulated in the cytoplasm 
(Fig. 14 IIa-d, and IVa-d, respectively). This result indicates that the amino acid at position 
76 in NLS2 motif does not play an essential role in the nuclear localization of TWIST. 
Although K76R mutant cannot inhibit nuclear localization by itself, it does play a 
synergistic role with the K38R mutant to further reduce nuclear localization which is 
described next. 
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Fig. 14: Subcellular localization of tagged protein. Subcellular localization of TWIST NLSs mutants is 
monitored following transient transfection in U2-OS cells. The subcellular localization of the mutated 
constructs K37R (NLS1) (I a-d) was in the cytoplasm of U2-OS cell, K73R NLS2 (IIa-d) was monitered in 
the cytoplasm of U2-OS cells. The subcellular localization of the mutated constructs K76R (NLS2) (IIIa-d) 
was limited in the nucleus of U2-OS cell, K77R NLS2 (IVa-d) was monitered in the cytoplasm of U2-OS 
cells, as observed by immunostaining. The (a) pictures show composite exposures of the objects, (b) pictures 
show DAPI-stained nuclei, (c) pictures show the TWIST~c-myc fusion proteins detected by mouse anti-c-
myc and Texas-Red-conjugated anti-mouse antibodies, (d) pictures represent exposures of the cytoskeletal F-
actin marked with Alexa Fluor 488 phalloidine. 
 
3.6.1 Subcellular localization of TWIST NLS2 mutants in combination with NLS1 
mutant 
To investigate potential synergistic or antagonistic regulation of nuclear localization of 
basic amino acid residues in both clusters, we altered the each NLS2 basic amino acid 
residue in combination with NLS1 clusters. TWIST having mutations at the positions K38R 
Ic Id
IIa IIb IIc IId
IIIa IIIb IIIc IIId 
IVa IVb IVc IVd 
Overlay DAPI anti-c-myc Phalloidine 
Ia Ib 
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(NLS1) and K76R (NLS2) inhibited the nuclear localization, suggesting that the two 
substituted residues in the first and the second cluster (K38R/K76R) strongly inhibit 
nuclear accumulation of TWIST protein. Similarly, the nuclear accumulation of 
(K38R/K77R) was also inhibited (Fig. 15, Table 13). These results confirm that both 
clusters work together in regulating nuclear localization of TWIST protein. 
 
Fig 15: Subcellular localization of mutant construct. NLS2 mutants K73R, K76R and K77R in the 
combination with NLS1 mutant K38R showing the cytoplasmic subcellular localization in the U2-OS cells in 
an indirect immunofluoresence microscopy: (a) merged images of the objects are specified, (b) DAPI stained 
cell nucleus, (c) anti-mouse c-myc and anti-mouse IgG antibodies coupled with Texas red coloured TWIST c-
myc fusion protein, (d) f-Actins cytoskeleton marked with Alexa fluorine 488 Phalloidine. 
Ia Ib Ic Id
IIa IIb IIc IId
IIIa IIIb IIIc IIId
Overlay DAPI Anti-c-myc Phalloidine 
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Table 13: Nuclear localization of wild type and mutant versions of TWIST 
Localization 
Clone Name NLS1 NLS2 
Nucleus Cytoplasm 
NLS1wt RKRR KRGKK +  
K38R RRRR KRGKK  + 
K73R RKRR RRGKK  + 
K77R RKRR KRGKR  + 
K76R RKRR KRGRK +  
K38R / K73R RRRR RRGKK  + 
K38R / K76R RRRR KRGRK  + 
K38R / K77R RRRR KRGKR  + 
The mutated amino acids are in bold and underlined 
 
3.7 In vivo interaction and co-localization of TWIST with E12 
The bHLH transcriptional factor protein requires either homo/heterodimer for DNA 
binding. It is reported earlier that E12 forms a heterodimer with other bHLH protein. To 
confirm that TWIST NLS are functionally significant for nuclear localization and that the 
interaction with E12 is required for translocation to the nucleus, E12 cDNA was fused into 
the eGFP-tag vector. In order to investigate the direct interaction between TWIST and E12, 
transient co-transfections of TWISTWT with E12, and TWIST mutants with E12 in U2-OS 
cells were performed. Co-localization was observed into the nucleus due to the heterodimer 
formation. TWISTWT with E12 was present in the nucleus (Fig. 16 Ia-d), simultaneous 
expression of E12 led to preferential nuclear localization of mutant TWIST K38R in all 
transfected U2-OS cells (Fig. 16 IIa-d). 
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Fig. 16: Co-transfection of E12 with NLS1, and NLS2. TWIST is fused with c-myc, and E12 with eGFP; 
both proteins co-localized in the nucleus of U2-OS cells in transient transfection. The results indicate the 
formation of a heterodimer of E12 with Twistwt (I a-d), and E12 with NLS1 mutated at K38R (II a-d) which is 
localized in the nucleus. The (a) pictures show composite exposure of the objects, (b) pictures show DAPI-
stained nuclei, (c) pictures show the TWIST~c-myc fusion proteins detected by mouse anti-c-myc and Texas-
Red-conjugated anti-mouse antibodies, (d) pictures represent exposure of E12 fused with eGFP. 
 
 
3. 8 Identification of functional domains in TWIST by using yeast-two-hybrid assay  
Yeast two-hybrid assay is a technique for identifying and analyzing protein–protein 
interactions. As we described early in the introduction that one aim of this work is the 
analysis of protein interactions of TWIST and its (NSEEE and WR) motifs with other 
proteins. 
 
3.8.1 Principle of the two-hybrid assay: a protein-protein interaction assay 
Two-hybrid assay is used to identify novel protein-protein interactions, confirm suspected 
interactions, and define interacting domains. In a BD Matchmaker Two-Hybrid assay, a 
bait gene is expressed as a fusion to the GAL4 DNA-binding domain (DNA-BD), while 
another gene or cDNA is expressed as a fusion to the GAL4 activation domain (AD) 
(Fields and Song 1989; Chien et al. 1991). When bait and library fusion proteins interact in 
a yeast reporter strain such as AH109 or mated AH109 and Y187 strains (Y187 alone has 
Overlay 
Ia 
IIa 
DAPI 
Ib 
IIb 
Anti-c-myc
Ic
IIc
eGFP 
Id
IId
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just MEL1 and LacZ; while AH109 alone has HIS3, ADE2, MEL1 and LacZ (Fig 17), the 
DNA-BD and AD are brought into proximity and activate the transcription of the reporter 
genes: ADE2, HIS3, LacZ, and MEL1 (Fig. 18). 
 
AH109 (Mating Partner) reporter gene constructs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Y187 (library host strain) reporter gene constructs 
 
 
 
 
 
 
 
Fig. 17: These figure shows the different reporter gene constructs in AH109 and Y187 strains. While 
Y187 only contains the sequences for LacZ and MEL1 reporter genes, the AH109 contains the sequences for 
HIS3 and ADE2 reporter genes. MEL1 encodes β-galactosidase and is an endogenous GAL4-responsive gene. 
In AH109, the HIS3, ADE2, and MEL1/lacZ reporter genes are under control of three completly heterologous 
GAL4-responsive UAS and promotor elements – GAL1, GAL2 and MEL1, respectively. 
 
DNA-BD and AD fusion proteins are created by cloning target cDNAs into the yeast 
expression vectors pGBKT7 or pGADT7. The pGBKT7 expressed proteins are fused to the 
GAL4 DNA-BD (DNA Binding Domain), while pGADT7 expressed proteins are fused to 
the GAL4 AD (Activation Domain)  
GAL1 UAS GAL1 TATA HIS
GAL2 UAS GAL2 TATA ADE2
MEL1 UAS MEL1 TATA MEL1 
MEL1 UAS MEL1 TATA LacZ
GAL1 UAS GAL1 TATA lacZ
MEL1MEL1 UAS MEL1 TATA
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Fig. 18: The two-hybrid principle. GAL4 protein is a yeast transcription factor that normally controls genes 
responsible for galactose metabolism. Each GAL4-responsive gene contains a target site called an Upstream 
Activating Sequence (UAS). When GAL4 binds the UAS, transcription is activated from a downstream 
promoter (Clontech). 
 
3.9 Cloning of different inserts into pGBKT7 bait vector 
To find out the possible binding partners using a yeast-two-hybrid assay, as a bait protein 
we used  
(1) TWIST ORF (NM_000474) 
(2) N-terminal region with NSEEE domain 
(3) C-terminal region with WR domain. 
The TWIST-ORF, N-terminal region containing NSEEE domain and C-terminal region 
containing WR domain were amplified without stop codons. For this purpose, the primers 
were designed as described in materials and methods (2.1.6: Table 2), which contained 
adapters EcoRI and BamHI. The amplified PCR products were double digested with both 
enzymes (in EcoRI buffer) and isolated by the gel extraction, and the insert was ligated with 
pGBKT7-vector, which was also digested with these restriction enzymes (Fig. 19). 
After transformation of these ligations in E. coli, several clones were to be seen on the agar 
plates, out of them 8 clones were picked for isolation of DNA from each plate and 
inoculated into a LB medium with Kanamycin (50 mg/ml). The isolated plasmids were 
digested with BamHI and EcoRI to check for successful ligation. The cloning products 
pGBKT7-TWIST, pGBKT7-NSEEE and pGBKT7-WR were transformed into E.coli. The 
final plasmids were sequenced to confirm the right frame and the absence of PCR artifacts. 
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Fig. 19: Agarose gel electrophoresis of the PCR products of TWIST and its motifs NSEEE and WR. 
Line 1 shows a 100 bp DNA ladder; Line 2 an insert of 270 bp size NSEEE clone; line 3 an insert of 619 bp 
TWIST clone; and line 4 an insert of 250 bp WR clone. 
 
3.10 Transformation of the bait plasmids into AH109 cells 
In order to examine the expression of the bait protein, the generated bait plasmids were 
transformed into commercially available chemically competent Saccharomyces cerevisiae 
AH109 yeast cells as described in materials and methods (2.5.2). DNA isolated from the 
yeast clones and the transformed plasmid were detected by PCR using the insert specific 
primers and the correct size inserts confirmed in all the three appropriate clones pGBKT7-
TWIST, pGBKT7-NSEEE and pGBKT7-WR. 
 
3.11 Testing the DNA-BD/bait protein for transcriptional activation 
First the self-activation of bait clones was verified. Self activation test is necessary to 
determine if fusion proteins (DNA-BD/bait protein) intrinsically activate unspecific 
transcription of reporter genes. In case of pGBKT7-TWIST, pGBKT7-NSEEE, and 
pGBKT7-WR in yeast strain AH109 no unspecific activation of reporter genes (for syntesis 
of adenine and histidine) was observed. The self-activation of reporter genes (without 
AD/prey) was checked on selective media plates lacking the three amino acids tryptophan, 
histidine, and adenine. 
i. SD/–Trp (Positive control) 
ii. SD/–Trp /–Ade/-His  
300 bp 
600 bp 
M NSEEE TWIST WR
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AH109 with pGBKT7-NSEEE vector (expressing DNA-BD/bait protein NSEEE) was 
transformed. Transformed AH109 clones grew only on the –Trp plates, because these plates 
select plasmid pGBKT7 carrying cells. The colonies did not grow on SD/–Ade/–His/–Trp. 
In contrast, if the colonies would appear on the SD/–Ade/–His/–Trp plates that would be 
unspecific transcription activation. However, this was not the case with our transformed 
clones, so that the constructs for the execution of a two hybrid screen were applicable (Fig. 
20). 
 
 
Fig. 20: Representing the testing of pGBKT7 with NSEEE bait Protein for transcriptional activation. 
(A) SD/–Ade/–His/–Trp plate showing no growth represents that there is no unspecific transcription 
activation, (B) –Trp plate showing the growth of AH109 containing pGBKT7–NSEEE vector. 
 
3.12 Testing the DNA-BD/bait protein for toxicity effects 
Many interactions could not be detectable due to increased cell mortality due to increasing 
toxicity, which is problematic for the execution of a two hybrid screen. To exclude this 
possibility, the toxicity of yeast cells growth was checked under control of the ADH1-
promotors. On the basis of the yeast cells growth incubated at 30°C, the density of the cell 
suspensions was determined after every two hours at 600 nm for both the yeast strain 
AH109 carrying unmodified cloning vector (pGBKT7) and of AH109 carrying the bait 
vector (pGBKT7-TWIST, pGBKT7-NSEEE, pGBKT7-WR). The toxicity of the bait 
protein was checked on the host strain to compare the growth rate in liquid culture of cells 
transformed with the empty DNA-BD vector and cells transformed with the DNA-BD/bait 
plasmid (pGBKT7-TWIST, pGBKT7-NSEEE, pGBKT7-WR). If the bait strain would 
BA 
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grow noticeably slower, the DNA-BD/bait protein would be toxic; thus, this strain may 
need to grow on agar plates in preparation for mating with the library. We could not detect 
any toxicity in our plasmids, because growth was as fast as AH109 carrying the unmodified 
plasmid. 
 
3.13 Mating of the bait vector with a pre-transformed human placenta cDNA library 
Three transformed yeast clones one from each TWIST, NSEEE, and WR were randomly 
selected from the –Trp plates. The mating of these randomly selected yeast clones named 
Tw-5, NSEEE-2, and WR-8 was accomplished as described in materials and methods 
(2.5.3). The paired yeasts were resuspended in SD minimal media and plated out directly 
on quadruple selective plates (QDO–lacking the amino acids Ade, His, Leu, Trp), so that 
only positive mated cells survived, in which fusion proteins interact. Additionally for 
negative control, the unmated pGBKT7-TWIST, pGBKT7-NSEEE, pGBKT7-WR as well 
as an aliquot of the placental library placed on QDO plates, which showed no growth. 
Twenty four clones for TWIST-ORF, 1200 clones for NSEEE domain, and 100 clones for 
WR domain were obtained. These clones were grown up approximately after three weeks 
of incubation at 30°C and given the numbers. Glycerine stocks were prepared from the 
clones grown on these plates. The plates were incubated further for one more week at 30°C 
and prepared DNA from the regenerated clones. TWIST and WR clones were again 
recultured on replica plates without 3-AT for futher experiments. On the other hand, 
NSEEE clones were recultured on replica plates which contains 50 mM of 3-AT to select 
out the stronger interacting candidates. Six hundred clones were grown on the replica plate 
containing 50mM 3-AT and these strong interacting clones were used for further 
experiments. 
 
3.14 Segregation of yeast clones in the bacteria 
The plasmids were isolated from the 24 TWIST, 600 NSEEE, and 100 WR yeast clones. 
The isolated plasmids were transformed in E. coli DH5α cells and selected on LB agar 
plates containing ampicillin (100 mg/ml). This step helps to get rid of the yeast genomic 
contamination as well as the selection of single clone. 
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3.15 DNA preparation from bacteria and analysis of positive clones by PCR 
DNA was prepared as described in materials and methods. The inserts were amplified from 
the library clones using the 1 µl template DNA and insert screening amplimer 5'-LD and 3'-
LD primers. PCR product was visualized on 1% agarose gel. 
 
3.16 Analysis of the entire TWIST positive clones by sequencing  
PCR products were cleaned by gel extraction using Qiagen column, prior to sequencing 
using an ABI PRISM 377 DNA Sequencer. The obtained sequences were screened with the 
help of sequencher 4.1 program and the sequences containing inserts were compared in the 
NCBI blast search.  
 
Table 14: List of the interacting proteins with entire TWIST 
Clone  Result  Remark Gene Bank Acc.No. 
TW1-2 mRNA Splicing factor 2 Nuclear protein L04636 
TW1-8 SEF2-1A Transcription factor HLH protein  M74718 
TW1-10 pre mRNA splicing factor 2 Nuclear protein L04636 
TW1-11 pre mRNA splicing factor 2 Nuclear protein L04636 
TW1-15 KIAA1376-protein unknown  XM_033042 
TW1.-16 KIAA1376-protein unknown  XM_033042 
TW1-18 Clusterin Sulfated-glycoprotein BC010514 
 
Out of 24 screened clones, 7 proteins were identified by BLAST searches. 4 of which 
(SF2p32, KIAA1376, SEF2, JAB1/CSN5) are candidates for an interaction with TWIST 
(Table 14). From the interacting candidates, SEF2 was selected for further studies because 
   Results 
- 69 - 
SEF2 is also a HLH transcription factor gene, and it is hypothesized that TWIST makes 
heterodimer with other HLH/bHLH protein  
 
3.17 Retest the direct interaction of TWIST with SEF2 protein in yeast cloning  
It is well known that in two-hybrid screens relatively false positive interactions were found 
frequently. In order to verify that the found clones were actually carriers of positive 
interactions that TWIST and SEF2 protein were real, we cloned the SEF2-ORF into 
pGADT7 prey vector. The pGADT7-SEF2 plasmids were transformed into chemically 
competent Y187 yeast cells as described in materials and methods. Transformants were 
spreaded on –Leu plate and incubated at 30°C for one week. The pGBKT7-TWIST plasmid 
was allowed to grow on –Trp plate for one week at 30°C. 
 
3.17.1 Yeast mating to verify the direct interaction of SEF2 protein with TWIST 
protein 
After the growth of clones on both plates one clone from each plate was selected and 
streaked out AH109 (pGBK T7-TWIST) with Y187 (pGADT7–SEF2) on YPD plate and 
allowed to grow at 30°C for 24 h (Fig. 21). Upon growth on the YPD plate a retro-plate 
was prepared with the help of velvet onto –Leu/–Trp plates to select only mated cells 
(irrespective growth if the fusion-proteins interact or not). The retro plates were again 
incubated atleast for next 2 or 3 days at 30°C, at which time growth was observed on the –
Leu/–Trp plates (Fig. 21). 
Mated clones were then dissolved in water from the –Leu/–Trp, and dropped out onto the 
QDO plates and the –Leu/–Trp filter plates. After one week incubation the growth on QDO 
plate and on the filter of the –Leu/–Trp filter plate was observed. 
To check the real interaction we used positive and negative controls onto QDO and –Leu/–
Trp filter plates. As a positive control we used p53/pGBKT7 clone transformed into AH109 
mated with Y187 strain containing T7-antigene in pGADT7-vector and as a negative 
control used p53/pGBK T7 in AH109 mated with LamC/pGADT7 which was transformed 
into Y187. These both mated strains grew on –Leu/–Trp plate at 30°C after 24 h of 
incubation. The p53 and LamC were unable to interact, and adenine and histidine genes not 
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transcribed. Therefore, mated cells with carrying non-interactive bait and prey could not 
grow on QDO plates and they are also negative for transcription of β-galactosidase (the 
filter-LacZ-test cells did not turn green-blue). 
 
3.17.2 Growth test for mated pGBKT7-TWIST and pGADT7-SEF-2 yeast clones 
To check the activation of reporter genes encoding histidine and adenine, strains carrying 
pGBKT7-TWIST (bait) and pGADT7-SEF-2 (prey) were mated. When bait and prey 
interact a transcription factor results, which then activates the transcription of the reporter 
genes histidine and adenine (and of β-galactosidase also). We found that the mated bait 
pGBKT7-TWIST and prey pGADT7-SEF-2 grew well on QDO plates (Fig. 21). Therefore, 
transcription of the reporter genes initiated because of interaction of bait pGBKT7-TWIST 
with prey pGADT7-SEF-2 proteins which is shown in Fig. 21. 
 
 
 
 
 
 
 
 
 
 
 
              
 
 
 
 
Fig. 21:  Yeast mating to verify protein interactions. (A) AH109 TWIST and Y187 SEF2 clones were 
streaked together on the YPD plate; (B) growth on –Leu/–Trp shows the successful cell mating (irrespective 
if fusion proteins interact); (C) TWIST and SEF2 proteins interaction was confirmed on QDO plate and (D) in 
Filter-LacZ test activation assay on filter/–Leu/–Trp plates. 
A 
C 
B
D
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3.17.3 Filter-LacZ-test activation of the reporter gene ß-galactosidase 
Filter-LacZ-assay was performed after 3 to 4 days cell growth on the filter/–Leu/–Trp 
plates. The filter was picked from the filter/–Leu/–Trp plates with sticking colonies and 
cells cracked in liquid nitrogen. After that, the filter containing cracked cells was placed on 
the new filter soaked in the freshly prepared Z buffer containing β-mercaptoethanol and X-
Gal (colonies at upper side). 
In this assay, p53/pGBKT7 clone transformed into AH109 mated with Y187 strain 
containing T7-antigene in pGADT7-vectors was used as a positive control and 
p53/pGBKT7 in AH109 mated with LamC/pGADT7 which was transformed into Y187 
used as a negative control. Both the positive control as well as the positive interacting 
partners (pGBKT7-Twist and pGADT7-SEF-2) also turned green. The time to obtain a 
green signal varied from a few minutes to several hours later -the excact time being 
dependent on the strength of the interaction. In case of green positive clones (pGBKT7-
TWIST and pGADT7-SEF-2), the transcription factor (interaction DNA-BD fusion protein 
and GAL4-AD fusion protein) activates β-galactosidase transcription resulting in X-Gal 
cleavage resulting in a green-blue colour which confirms the strong interaction of TWIST 
with SEF2 (Fig. 21). 
 
3.17.4 Confirmation of protein interactions in mammalian cells 
In order to examine, whether proteins possessing same subcellular address can colocalize 
with each other, they have to be viewed simultaneously in U2-OS cells. To accomplish this, 
the TWIST protein under investigation was tagged to c-myc and combined with strains 
expressing its potential interaction partner fused to eGFP. For this SEF2 open reading 
frame was subcloned into eGFP-N1 vector by using EcoRI. To verify the interaction of the 
SEF2 with TWIST protein in vivo, NLS rescue assay was performed. In this assay a NLS-
mutated TWIST, which is unable to be transported into the nucleus, was cotransfected with 
SEF2 to check whether the lack of a functional NLS could be compensated by 
heterodimerization and subsequent co-import of the two proteins by fluorescence 
microscopy. While no nuclear localization of TWIST could be observed in the cells co-
transfected only with 38NLS mutated TWIST, co-localization of both proteins in the 
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nucleus was detected in the cells co-transfected with both TWIST NLSmut and SEF2 
expression vector (Fig. 22). 
 
 
Fig. 22: In vivo NLS rescue assay to study the ability of SEF2 to assist in the nuclear localization of 
TWIST NLSmut. Ia-d Show the subcellular localization of the mutated construct TWIST K38NLSR fused 
with C-myc due to the mutated NLS the protein mislocalized into the cytoplasm; IIa-d NLS rescue by 
interaction of SEF2 and mutated TWIST K38NLSR. Because of the interaction between these two proteins 
the functional NLS of TWIST with SEF2 is sufficient to get them both imported into the nucleus due to 
formation of heterodimer. The picture Ia-IIa show composite exposures of the objects, Ib-IIb represents the 
DAPI stained nuclei, Ic-IIc show the TWIST-cmyc fusion proteins detected by mouse anti-c-myc and Texas 
red conjugated anti mouse secondary antibody. In picture Id F-actin fluor 488 phalloidine showing the 
cytoskeleton, IId represents an exposure of SEF2 fused with eGFP. 
 
3.18 Evaluation of NSEEE clones from the yeast two hybrid 
In the first screening, more than 1000 yeast clones were obtained, In order to investigate the 
strongest interaction we used 3-amino-1,2,4-triazole (3-AT). This is a competitive inhibitor 
of the yeast HIS3 protein (His3p). 3-AT is used to inhibit the low levels of His3p leaky 
expression to better suppress background growth on SD medium lacking His (Fields 1993; 
Durfee et al. 1993). 
Transformants derived from AH109 showed slightly elevated HIS3 expression because of 
intrinsic DNA-binding properties of the bait protein. A small amount of 3-AT is generally 
sufficient to suppress background growth on SD/–His. However, if the both HIS3 and 
IIa IIb IIc IId 
Ia Ib Ic Id 
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ADE2 are expressing, it is generally not necessary to suppress HIS3 leakiness in the initial 
library screen. 
To optimize the 3-AT concentration, AH109 transformed with NSEEE bait plasmid on the 
SD/–Trp/–His plates containing 3-AT ranging from 0 to 50 mM (0, 2.5, 5, 7.5, 10, 12.5, 15 
mM…..50mM). It is optimized that in case of NSEEE clones the strong interactions were 
obtained with 50 mM 3-AT concentration. Six hundred strongly interacted clones were 
obtained in this assay. DNA was extracted from these clones and amplified by using the 
vector specific primer in a PCR reaction. The nucleotide sequences of amplified products 
were sequenced and BLAST searched for the interesting interacted candidates. Several 
interesting clones found in this screening given below (Table 15). 
 
Table 15: List of important screened NSEEE clones from yeast-two-hybrid assay 
Clone  Result  Remark Gene Bank 
Acc.No. 
NSEEE(1-A1) galactose mutarotase (aldose 1-epimerase), BC014916 
NSEEE(1-A3) Homo sapiens secreted 
protein 
osteonectin BC072457 
NSEEE(1-A4) Homo sapiens chorionic 
somatomammotropin 
hormone 1 
Placental lactogen BC062775 
NSEEE(1-A5) Homo sapiens ets variant 
gene 5 
ets-related molecule NM_004454 
NSEEE(1-A8) full-length cDNA clone 
CS0DI051YC24 of 
Placenta 
Placental protein CR626712 
NSEEE(1-A11) Homo sapiens KIAA0892 
(KIAA0892), mRNA 
Placental protein  NM_015329 
NSEEE(1-B1) Homo sapiens chorionic 
somatomammotropin 
hormone 1), 
placental lactogen BC002717 
NSEEE(1-B2) Homo sapiens pregnancy 
specific beta-1-
glycoprotein 3 
Placental protein BC005924 
NSEEE(1-B3) Homo sapiens 
chromosome 17 
unspecific AC040958 
NSEEE(1-B5) Homo sapiens clone CTB-25P15 AC011399 
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chromosome 5  
NSEEE(1-B7) Homo sapiens tyrosine 3-
monooxygenase 
participation in the 
protein kinase C 
signaling pathway 
BC001359 
NSEEE(1-B9) Homo sapiens surfeit 4 
(SURF4), 
integral membrane 
protein 
NM033161 
NSEEE(1-B11) Spast gene SPG4-linked 
hereditary spastic 
paraplegia. 
AJ246003 
NSEEE(1-C4) unspecific - - 
NSEEE(1-C6) Homo sapiens chorionic 
somatomammotropin 
hormone 1  
(placental lactogen) NM_022642 
NSEEE(1-C8) Homo sapiens chorionic 
somatomammotropin 
hormone 1  
placental lactogen NM_022642 
NSEEE(1-C12) Homo sapiens chorionic 
somatomammotropin 
hormone 1  
placental lactogen NM_022642 
NSEEE(1-D1) unspecific - - 
NSEEE(1-E2) Homo sapiens pregnancy 
specific beta-1-
glycoprotein 4 
Placental protein BC063127 
NSEEE(1-E7) False positive   
NSEEE(1-E9) False positive   
NSEEE(1-E12) RP1-134O19 on 
chromosome 1p36.11-
36.33  
 
Contains the 3' end 
of the gene for 
SMART/HDAC1 
associated repressor 
protein (SHARP), 
the 3' end of the 
ZNF151 genefor zinc 
finger protein 151 
(pHZ-67) and a CpG 
island, complete 
sequence 
AL034555 
NSEEE(1-F6) unspecific - - 
NSEEE(1- F8) Homo sapiens chorionic 
somatomammotropin 
hormone 2 (CSH2), 
human placental 
lactogen genes 
 
NM_022646 
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transcript variant 4 
NSEEE(1-G1) False positive   
NSEEE(1-G4.1) Homo sapiens splicing 
factor, arginine/serine-
rich 3 
Placenta, 
choriocarcinoma 
BC000914 
 
NSEEE(1-G4.2) False positive   
NSEEE(1-G5) Homo sapiens PC2 
(positive cofactor 2, 
multiprotein complex) 
 
glutamine/Q-rich-
associated protein 
BC005027 
 
NSEEE(1-G6) False positive   
NSEEE(1-G8) Homo sapiens chorionic 
somatomammotropin 
hormone 1  
(placental lactogen) NM_022642 
NSEEE(3-A8) unspecific - - 
NSEEE(3 -B3) Unknown genomic 
sequence on chromosome 
10 
unknown AL359878 
NSEEE(3 -B4) Homo sapiens 3 BAC 
RP11-26P16 (Roswell 
Park Cancer Institute 
HumanBAC Library) 
complete sequence 
 AC117416 
NSEEE(3-B5) Homo sapiens chorionic 
somatomammotropin 
hormone 1  
(placental lactogen) NM_022642 
NSEEE(3-B8) cDNA clone of 
Neuroblastoma 
Neuroblastoma 
protein 
CR607127 
NSEEE(4-B9) prostaglandin D2 
synthase gene 
prostaglandin D2 
synthase 
M98538 
 
NSEEE(4-C6) Homo sapiens FK506 
binding protein 9, 
 NM_007270 
NSEEE(5-A62) Homo sapiens asparagine 
synthetase (ASNS), 
 NM_001673      
NSEEE(5-A7) Homo sapiens ALR-like 
protein mRNA 
involved in leukemia 
and brain 
development 
AF264750 
NSEEE(5-B4) Homo sapiens chorionic 
somatomammotropin 
(placental lactogen) NM022641 
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hormone 1 transcript 
variant 3 
NSEEE(5-B6) tissue inhibitor of 
metalloproteinase 2 
 NM_003255 
 
NSEEE(5-C6) Synaptosomal 
associateprotein 
 BC000148 
NSEEE(5-G7) Homo sapiens cDNA 
FLJ38210 fis 
highly similar to 
Mus musculus 
neuronal cell 
adhesion molecule 
(Punc) mRNA 
AK095529 
 
NSEEE(5-G9) RAS p21 protein 
activator 
GTPase activating 
protein 
BC020761 
 
Among them 6 candiates are recognized most promising candidates. These are ETV5, 
Homo sapiens SURF4, Spastin, Homo sapiens FK506 binding protein9, Homo sapiens 
tissue inhibitor of metalloproteinase 2, and ALR proteins.  
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4 Discussion 
In eukaryotic cells, evolution of the nuclear envelope to define cytoplasmic and nuclear 
compartments led to a physical separation of transcription and translation. Nuclear 
proteins (structural polypeptides or regulatory factors), which are implicit in this 
compartmentalization and are synthesized in the cytoplasm, have to be imported into the 
nucleus to exert their activities for cellular growth and differentiation. 
The active transport of karyophillic proteins allows another way to exert gene regulation 
by modulating localization in the nucleus (Vandromme et al. 1996) in contrast to other 
small molecules that can freely diffuse over the nuclear pore complex. Transport across 
the pore complex is a two-step process involving binding to the pore complex and 
translocation across the lumen of the pore complex (Dinwall and Laskey 1991; Nigg et 
al. 1991; Boulikas 1994, Görlich and Mattaj 1996). Various studies on the nuclear 
localization signal have led to the concept that transport across the nuclear envelope is 
an active process mediated by one or more nuclear localization signal sequences present 
within either the protein or an associated cofactors (Reviewed by Garcia-Bustos et al. 
1991; Nigg et al. 1991). Specialized transporter protein known as NLS-binding proteins 
can recognize one or several nuclear-localization-signal (NLS) sequences in the primary 
structure of the target protein and transports these proteins to the nucleus (Boulikas 
1994). 
NLSs have been characterized in a growing number of nuclear proteins using two 
criteria: NLS is sufficient to promote nuclear accumulation of an otherwise cytoplasmic 
protein when fused to it genetically or biochemically and, deletion of an NLS(s) from a 
nuclear protein leads to it cytoplasmic retention. Although a strict consensus does not 
yet exist, it appears that most NLSs are in short and linear sequences (from 5 to 12 
amino acids) generally containing several basic residues (arginine and lysine) (Boulikas 
1994). Moreover, presence of a NLS on a protein is not always sufficient to direct its 
nuclear import, as the NLS might be modified or masked so that it is no longer 
recognized by the nuclear transport machinery. Masking the NLS might be achieved by 
post-translational modifications, such as phosphorylation and/or by intra- or inter-
molecular interactions. The protein is then sequestered in the cytoplasm until the NLS is 
unmasked. Furthermore, an NLS-containing protein might be anchored in the cytoplasm 
by binding to another protein, as a result of a specific amino acid sequence whose effect 
is dominant (Vandromme et al. 1996). 
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NLS motifs are not limited to only nuclear protein contains but can be exhibited by 
some cytoplasmic proteins (Smith et al. 1985). However, these proteins are not 
available for a nuclear import, since they are held back due to their respective function 
by association with diaphragm proteins or cytoplasmic structures in the cytoplasm 
(Boulikas 1994).  
Mutations in sequences relevant for nucleus transport, which exhibit resident proteins, 
shuttle molecules or any interaction partners in the cell nucleus, can lead to a false 
distribution of these proteins in the cell leading to loss of functionality. The expression 
of the target genes can then be impaired due a lack of nuclear import by the 
transcription factor. 
Regulation of TWIST1 gene expression was analyzed to characterize the poorly 
understood amino terminal region of the bHLH transcription factor TWIST. 
In this study we provide evidence that nuclear import of the bHLH TWIST protein is 
mediated by two functional nucleus localization signals sequences present in the N- 
terminal region of the TWIST protein and that the heterodimerization of TWIST with 
class A bHLH proteins is prerequisite for nuclear translocation of TWIST protein. NLSs 
of TWIST protein substitutions were analyzed for the functional consequences. 
 
4.1 Nuclear import directed around the functionality of two putative nucleus 
localization signals of TWIST 
According to Boulikas (1994) postulate, the basic region of transcription factors often 
contains potential nucleus localization signals, although in the case of the bHLH 
transcription factors TWIST (amino acid position 108-120) no nucleus localization 
signals are observed in the basic domain. The identification of the TWIST NLSs 
therefore represents an important step in the understanding the regulation of TWIST 
localization. Two classical nucleus localization signals sequences were detected from 
data base searches at the N-terminal of the TWIST protein, which are found to be rich in 
basic amino acids lysine and arginine. The NLSs characterized in TWIST fulfil the 
requirements for nucleus localization signals as postulated by Boulikas criteria. The first 
cluster (NLS1) consists of 37-RKRR-40 and the second cluster (NLS2) consists of 73-
KRGKK-77 respectively (Fig 23). 
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Fig. 23: Potential topogene core localization signals within the Twist protein sequence. The grey 
coloured boxes amino acids represent the potential NLS1 and NLS2 of TWIST, at the positions of the 
amino acids 37-40 (RKRR) as well as 73-77 (KRGKK), respectively. The glycine-rich as well as the 
basic domain are present at the amino acid positions 80-98, and/or 108-120. The Helix Loop Helix 
domain (aa position 121-160) is responsible for the homo and/or heterodimerization of the transcription 
factor TWIST. 
 
NLS was first reported by Prendergast et al. (1991), who characterized NLS1 in Myn 
(murine homolog of Max) protein and reported that it forms a DNA-binding complex 
with c-myc oncoprotein through a helix-loop-helix/Leucin Zipper. Consistent with this, 
Blackwood and Eisenmann (1991) reported that the neither max nor myc alone exhibit 
appreciable DNA binding. 
The second putative NLS sequence (NLS2) was reported to contain arginine and lysine 
separated by a glycine amino acid (KRGKK). This motif for nuclear import was 
reported as functional transportation signal in the oestrogen receptor (Green et al. 1986). 
Different types of mutations in TWIST protein such as missense or nonsense are 
responsible for the clinical features of the Saethre-Chotzen syndrome. However, the 
mutation in conserved region of the Twist proteins affects their nuclear localization and 
inability to bind the DNA (Takebayshi et al. 1996). As the recognition of NLS motifs 
can involve tertiary structure recognition as well as amino acid sequence, (Boulikas 
1994; Vandromme et al. 1996), it is important to carry out mutational studies without 
compromising protein conformation in the N-terminal range of the TWIST protein to 
avoid masking of potential NLS motifs which can be analyzed by the c-myc-epitope. 
For this reason the nucleotide sequences coding for the c-myc-epitope was fused at the 
5'-end of TWIST cDNA fragment and subcellular localization was examined in U2-OS 
cells by the indirect immune fluorescence microscopy. 
1 202 aa
bHLH 
37-40 73-77
NLS1 
RKRR KRGKK 
NLS2 
1 606 bp
GC Domain NSEEE WR Domain 
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The localization of TWIST protein predominantly in the U2-OS cell nucleus is 
consistent with previous reports of TWIST protein localization in COS7 cell nucleus (El 
Ghouzzi et al. 2000), suggesting that nuclear transport is an active process. Although 
the small molecular weight of TWIST protein (approximately 25 kDa), could allow it to 
localize easily to the core pore complex by free diffusion, it is assumed that Twist is 
imported actively into the nucleus during embryonic development of vertebrates and 
invertebrate, as it’s transcriptional activity is critical during these developmental stages. 
Intracellular communication between nucleus and the cytoplasm occurs through nuclear 
pore complexes (NPCs) present in the nuclear envelope that allow passive diffusion of 
molecules smaller than 40 to 60 kDa (up to 9 nm in diameter) (Görlich and Kutay 1999; 
Rout and Aitchison 2000). However, larger macromolecules, and even some proteins or 
RNAs smaller than 20 to 30 kDa, such as histones and tRNA, might be transported 
actively in a multi-step manner through NPCs, usually involving proteins encoding one 
NLS and using NLS-mediated import machinery (Lee and Aitchison 1999). 
 
Substituted NLSs were studied in order to know that if the mutations in NLSs motifs 
altered the TWIST function through different mechanism. First a series of amino acid 
point mutations were constructed, resulting in lysine to arginine substitutions in the 
NLS of a TWISTcDNA~cmycN fusions construct. The subcellular localization of the 
NLS mutated constructs were analyzed by an immune fluorescence microscopy in U2-
OS cells, so that both the nucleus import mechanism as well as nucleus localization 
signals functionality could be assayed. From these studies it was determined that 
alteration of the both NLS sequences resulted in a great loss of TWIST nuclear import. 
It is also observed that the either NLSs individually is required but not sufficient to 
promote nuclear translocation of the TWIST protein i.e. they synergistically play a role 
in the TWIST protein import.  
Funato et al. (2005) reported a novel mutation at 115C>G, encoding A39G, located 
within the putative NLS1, in a SCS patient, where both nuclear and cytoplasmic 
expression was observed in COS7 cells. TWIST protein carrying NLS1 (K38R) was 
found to be retained in the U2-OS cell cytoplasm in this study (Fig. 13), consistent with 
the observations of Funato and co-workers, and confirm that the N-terminal NLS 1 is 
functional in nuclear import. Comparable observations were made for murine Dermo-1, 
a bHLH protein encoded by the TWIST2 gene, in which engineered replacement of the 
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equivalent NLS (also containing the RKRR sequence) by four alanine residues impaired 
nuclear import (Gong and Li 2002). 
Similarly, the functionality of NLS2 was checked in the U2-OS cells to substitute the 
amino acids at the positions K73R, K76R, and K77R. It was observed that NLS2, like 
NLS1, also played an essential role in the nuclear import of TWIST protein. From these 
findings, it is concluded that altered NLS variants carrying substitutions at all the above 
mentioned positions, except the substituted, lead to cytoplasmic retention. By contrast, 
NLS2 with substitutions at position K76R was found to be localized predominantly in 
the nucleus, suggesting that the in NLS2 lysine at position K76R alone does not play 
essential role in the nucleus import. By contrast, NLS2 K76R in combination with 
mutated NLS1 was found sufficient to promote the nuclear import of TWIST protein. 
 
4.2 Dimerization and nuclear entry of TWIST protein in U2-OS cells 
In class B bHLH proteins to which TWIST belongs, the helix-loop-helix are known to 
form heterodimers with members of class A bHLH transcription factors including E12 
and E47 (collectively termed as E2A), which are alternatively spliced products of the 
TCF3 gene (Murre et al. 1989a; Murre et al. 1989b), and E2-2, E2-5 (Henthron et al. 
1990). In some proteins like MyoD the NLS are often present in the bHLH region, but 
this is not the case with TWIST protein. Missense mutations of the bHLH region of 
TWIST either lose the ability to recruit partner bHLH molecules (such as E2A) or 
abolish DNA binding, and hence fail to repress E2A-dependent activation of p21 
expression (El Ghouzzi et al. 2000, 2001; Funato et al. 2001), resulting in 
craniosynostosis. TWIST/E2A heterodimers suppress osteoblast differentiation by down 
regulating the expression of CDKN1A, which encodes p21/WAF1/ CIP1 (referred as 
p21), an inhibitor of cyclin-dependent kinases (Harper et al. 1993; Funato et al. 2001). 
In a co-transfection assay, the findings in this study suggest that E12 strongly interacted 
with TWIST in U2-OS cells. Heterodimerization of HLH proteins have been previously 
reported to take place in the nucleus due to nuclear import (El Ghouzzi, 2000). This 
study confirmed that the expected nuclear localization of the wild-type TWIST protein 
appears to be a direct consequence of the in vivo interaction with E12. 
It is also well known that a missense mutation in the helical domain lead to complete 
TWIST hetrodimerization loss with E12 and resulting in mislocalization (El Ghouzzi et 
al. 2000). Consequently, the nucleoplasmic location of TWIST proteins carrying single 
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amino acid change in the NLS1 as well as in NLS2 with E12 result from the dimer 
formation. This study concludes that in cotransfection experiments, E12 can 
functionally compensate non-functional NLS in TWIST. 
TWIST protein loses its function as negative modulator during the differentiation of 
different mesodermal layers e.g. in the myogenesis, osteogenesis or neurogenesis 
(Hebrok et al. 1994; Stoetzel et al. 1995; Spicer et al. 1996; Hamamori et al. 1997). By 
contrast Vandromme and coworkers (1995) reported that a deletion in bHLH factors in 
MyoD is responsible to loss the dimerization ability with E12 and concluded that these 
proteins can be transported also as monomers into the cell core. 
Twist can interact with other proteins through its N-terminal and C-terminal domains. In 
addition, individual homodimer and heterodimer bHLH combinations can confer 
differences in DNA binding affinity, target preference site and biological activities, 
emphasizing that partner choice is an additional key regulation point for bHLH proteins 
(Jones 1990; Kadesch, 1993). Besides the two putative nucleus localization signals and 
bHLH, two additional motifs are also present (NSEEE and WR) in Twist proteins. The 
function of these motifs in Twist is not yet fully understood. In order to investigate the 
characterization of these two domains in TWIST protein a yeast –two-hybrid assay was 
performed. 
 
4.3 Yeast-two-hybrid systems to interact the protein using TWIST and its domains  
Yeast-two-hybrid assay is used to analyse the target protein’s ability to dimerize with 
bait protein. There are several advantages to using the two-hybrid system to isolate 
novel cell type specific partners for TWIST and its motifs. It is a functional assay, and 
based only on the ability of proteins to dimerize. The assay is also highly sensitive and 
specific. Additionally, there is an evidence that the bHLH motif interacts with co-
regulators to induce muscle specific transcription (Brennan et al. 1991; Davis et al. 
1990). 
There is considerable evidence for cell type-specific bHLH proteins involvement in the 
control of tissue-specific gene expression in vertebrates. (i) Twist and several related E- 
proteins that are widely expressed, dimerize preferentially with cell type-specific HLH 
proteins such as MyoD and myogenin (Chakraborty et al. 1991; Murre et al. 1989a, 
1989b). (ii) Id, a negative regulator of HLH protein DNA binding, is expressed in many 
undifferentiated cell types and is down regulated upon activation of differentiation, 
which has been proposed to release E-proteins to dimerize with cell type-specific 
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partners (Benezra et al. 1990). (iii) many tissue specific genes contain E-boxes in their 
control regions that are essential for cell type specific transcription (Murre et al. 1989a; 
Olson, 1990; Sartorelli et al. 1992), and (iv) the involvement of numerous cell type-
specific bHLH proteins in cell fate specification in Drosophila suggests that these 
proteins constitute a conserved mechanism for regulation of cell type specific 
transcription (Alonso and Cabrera 1988; Thisse et al. 1988). 
It is evident that ‘twist’ gene can be isolated from species ranging jellyfish to man, it is 
less apparent what the actual functions of Twist and its domains are in these different 
organism. Twist protein was shown to contain an amino terminal histone-acetyl-
transferase (HAT) binding domain (Hamamori et al. 1999), for which the NSEEE 
domain could be possibly responsible. The N-terminal region of D-Twist (amino acid 1-
330) has been implicated in transcription activation (Shirokawa and Courey 1997) and 
in amino acids 141–330 of D-Twist have been shown to interact with TAF110, a 
subunit of the TFIID complex, to mediate target gene activation (Pham et al. 1999). 
 
The WR motif is highly conserved from jellyfish to vertebrates located at the C-terminal 
end of Twist (Spring et al. 2000), but the function of this domain was uncharacterized at 
the beginning of this study. However, a nonsense mutation in the TWIST1 gene just 
before the WR motif also causes a mild appearance of the Saethre–Chotzen syndrome, 
suggesting that C-terminal domain is required either for TWIST activity, for the 
stability of its mRNA or for normal protein folding (Gripp et al. 2000). The M-Twist C-
terminal region point mutations protein prevented its interaction with the transcription 
factor MEF2 (Spicer et al. 1996). 
Furthermore, Bialek et al. (2004) reported that WR domain is the binding domain for 
RunX2 protein, the master regulator of osteoblast differtiation. The interaction of 
TWIST (Twist box) and the Runt domain of RunX2; prevents DNA binding and gene 
activation by RunX2. A point mutation in the Twist box of Twist-1 leads to accelerated 
bone formation in both heterozygous and homozygous mice. Bialek et al. (2004) 
conclude that Twist-1 (previously called Twist), and Twist-2 (previously called Dermo-
1) regulate the development action of RunX2 in bone formation through the direct 
interaction of these proteins. WR domain could be functional due to the interaction with 
transcription factors such as RunX2 or other unknown transcription factors. In this 
study, TWIST WR domain was evaluated to find out the interacting partners using 
yeast-two hybrid assay. One hundred twenty clones were obtained, but after screening 
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of these 120 seems positive clone by blast search analysis, the real interaction could not 
be detected. It is well known that in two hybrid screen relatively false positively 
interactions were found frequently. It might be the possibility that the interaction of this 
domain with other proteins needs the bHLH motif. 
 
4.3.1 Potential interacting partners of TWIST  
Several interesting candidates are found interacted with entire TWIST and NSEEE 
domain by using a human placental cDNA library in this study, are discussed below. 
 
4.3.1.1 SEF2 Protein 
As discussed above, TWIST heterodimerizes with other bHLH transcriptional factor 
proteins. Hamamori et al. (1997) reported a connection of Twist and MyoD shown to 
prevent the specific activation of target genes for osteogenic differentiation-a substantial 
mechanism of the molecular pathogenesis of the Saethre–Chotzen syndrome. In an 
attempt to further explore this interconnection of cross-talk between different types of 
transcription factors, a potential candidate of bHLH transcription factor encoded E2-2 
protein also known as immunoglobulin transcription factor 2, (ITF2 or SEF2-1B or 
SEF2 or TCF4) referred here as SEF2 was identified, which is located on chromosome 
18q 21.1 (Breschel et al. 1997). 
The strong expression of SEF2 in the brain tissue ( Liu et al. 1998); its binding and 
regulatory activity with some neuron-and neuroendocrine-specific promoters, including 
the tyrosine hydroxylase enhancer and the somatostatin receptor II promoter (Yoon and 
Chikaraishi 1994; Pscherer et al. 1996), along with SEF2 upregulation in osteoblast 
differentiation (Beck et al 2001) makes it an interesting candidates. Based on these 
previous reports and the interaction of SEF 2 with TWIST reported in this study along 
with their possible hetero dimerization confirmed by in vitro and NLS rescue assay, it 
might be possible that the heterodimer of TWIST with SEF2 involved in the 
osteogenesis and brain development and makes an interesting topic for further 
investigation. 
Furthermore TWIST and SEF2 expression was confirmed in the U2-OS cells. The 
hypothesis was based on the observation that if the cotransfection with SEF2 NLS 
deficient TWIST restores into the nucleus then it could be responsible for a real 
interaction. As NLS deficient TWIST is unable to localize into the nucleus, this study 
illustrates that TWIST can form a functional complex together with SEF2-like with 
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E12. It is concluded that since heterodimerization of both proteins has to occur in the 
cytoplasm prior to nuclear import, the expected nuclear location of the wild type 
TWIST protein appears to be a direct reflection of the in vivo interaction with SEF2. 
Hence, SEF2 appears as a putative partner in vivo for regulating the TWIST 
transcriptional activity. Interestingly, TWIST and E2A transcripts have been detected in 
mouse osteoblastic cells (Murray et al. 1992), and the inhibitory effect of TWIST in 
osteogenic differentiation (Bialek et al. 2004), the TWIST-SEF2 hetrodimer might be a 
negative regulator of transcription in the human osteoblastic cells. 
 
4.3.2 Potential interaction partner of NSEEE domain  
Using selection plates many different potentially positive clones were isolated, and 
some of these clones possibly could be very interesting candidate proteins which are 
described below. 
 
4.3.2.1 Homo sapiens ETS variant gene  
The most promising interacting candidate was the NSEEE clones (1-A5) i.e. Homo 
sapiens ETS variant mRNA (Etv5) which corresponds, gene bank AccNo NM_004454. 
The ETS family transcription factors have in common the ETS-domain, an 85 amino-
acid domain organized in a winged helix-turn-helix (HTH) structure and responsible for 
DNA-binding to the specific core sequence GGA (A/T) (Sharrocks 2001). These factors 
can be sub-classified in 13 groups according to the amino-acid conservation not only in 
the ETS-domain but also in other domains, such as transactivation or protein interaction 
domains. The PEA3 group is made up of three members: Pea3 (E1af, Etv4), Er81 (Etv1) 
and Erm (Etv5). These three factors are more than 95% identical in the ETS-domain, 
and highly conserved in the N-terminal acidic and C-terminal transactivation domains 
(de Launoit et al. 2000; Kurpios et al. 2003). These transcription factors are involved in 
developmental processes and oncogenesis (de Launoit et al. 2000). For example, in the 
mammary gland, their overexpression is observed in certain human breast cancers as 
well as in oncogene-induced mammary tumors (Baert et al. 1997, Shepherd and Hassell 
2001). They are also expressed upon different stages of normal mammary gland 
development, from embryonic emergence to postnatal postnatal evolution (Chotteau-
Lelievre et al. 2001; Chotteau-Lelievre et al. 2003), with high levels of expression 
during extensive ductal outgrowth and branching. As mentioned above Twist, a master 
regulator of morphogenesis, plays an essential role in tumor metastasis (Yang et al 
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2004), offering the possibility that TWIST NSEEE domain is able to interact with Etv5 
to play a role in human breast cancer thereby making this interaction a interesting topic 
for further investigation.  
 
4.3.2.2 Homo sapiens surfeit locus 
The other important interacting protein was NSEEE clone (1-B9) that contains integral 
membrane Homo sapiens surfeit 4 (SURF4) which corresponds, gene bank Acc. No. 
NM_033161. 
The mouse Surfeit locus contains at least six housekeeping genes (Surf-1 to -6) 2 in the 
tightest mammalian gene cluster (Garson et al. 1995; Huxley and Fried 1990), with no 
DNA sequence or amino acid homology among the six surfeit genes. The locus contains 
a number of novel features including overlapping genes (Williams and Fried, 1986) and 
a bidirectional transcriptional promoter (Lennard and Fried 1991). The 5’ end of each of 
the genes is associated with a CpG-rich island (Huxley and Fried 1990). The Surf-3 
gene encodes the ribosomal protein L7a (Giallongo et al. 1989), the Surf-4 gene 
encodes an integral membrane protein associated with the ER (Reeves and Fried, 1995, 
the two proteins encoded by Surf-5 as a result of differential splicing are cytoplasmic 
(Garson et al. 1995, 1996), the Surf-6 protein is located in the nucleolus (Magoulas and 
Fried, 1996), and a yeast homologue of the Surf-1 gene encodes a mitochondrial 
membrane protein involved in respiration (Mashkevich et al. 1997). The human Surfeit 
locus maps to 9q34.2 (Yon et al. 1993), and the mouse Surfeit locus maps to a syntenic 
region within the proximal portion of chromosome 2 (Stubbs et al. 1990). The Homo 
sapiens Surfeit 4 protein is not yet well characterized. 
 
4.3.2.3 Spastin protein 
The other interacting candidate was the NSEEE clones (1-B11) i.e. Spastin protein 
contains SPG4-linked hereditary spastic paraplegia corresponds, gene bank Acc. No. 
AJ246003. 
This protein is involved in an autosomal dominant hereditary spastic paraplegia (AD-
HSP), a genetically heterogeneous neurodegenerative disorder characterized by 
progressive spasticity of the lower limbs. The hereditary spastic paraplegias comprise a 
group of inherited neurological disorders in which the primary manifestation is spastic 
weakness of the lower extremities. Troyer syndrome is an autosomal recessive form of 
spastic paraplegia caused by a frameshift mutation in the spartin (SPG20) gene. The 
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SPG4 locus at chromosome 2p21–p22 has been shown to account for 40–50% of all 
AD-HSP families. Sequence analysis of this gene in seven SPG4-linked pedigrees 
revealed several DNA modifications, including missense, nonsense and splice-site 
mutations. Both SPG4 and its mouse orthologue were shown to be expressed early and 
ubiquitously in fetal and adult tissues. The sequence homologies and putative 
subcellular localization of spastin suggest that this ATPase is involved in the assembly 
or function of nuclear protein complexes (Hazen et al. 1999). Futhermore, Bakowska et 
al. (2005) suggested that spartin might be involved in endocytosis, vesicle trafficking, or 
mitogenic activities and that impairment in one of these processes may underlie the long 
axonopathy in patients with Troyer syndrome. The interaction of TWIST NSEEE with 
spastin protein could be possible to play an important role in the development of the 
lower limbs and might be an interesting topic for further investigation. 
 
4.3.2.4 Homo sapiens FK506 binding protein 9 
The other interacting candidate NSEEE (4-C6), was Homo sapiens FK506 binding 
protein 9 corresponds, gene bank Acc. No. NM_007270. 
The FK506-binding proteins (FKBPs) are peptidyl–prolyl cis/trans isomerases (PPIases) 
that bind the immunosuppressive drug FK506. It is localized to the endoplasmic 
reticulumand associates with tropoelastin in the secretory pathway. Unlike other FKBP 
characterized so far, FKBP65 is developmentally regulated and may be intimately 
involved in organogenesis (Patterson et al. 2002). 
 
4.3.2.5 Homo sapiens tissue inhibitor of metalloproteinase 2 
The other important interacting candidate was the NSEEE clones (5-B6) i.e. tissue 
inhibitor of metalloproteinase 2 protein corresponds, gene bank Acc. No. NM_003255. 
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) 
play a role in the processes of extracellular matrix degradation. Changes in their 
expression levels have been observed in various tumor types, including lung carcinoma 
and breast cancer (Gouyer et al. 2005). However, their clinical significance and their 
prognostic importance in the progression of non small cell lung carcinoma (NSCLC) 
remain to be characterized. 
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4.3.2.6 ALR protein  
The other important candidates was NSEEE clones (5-A7) i.e. protein ALR protein 
corresponds, gene bank Acc. No. AF264750. 
A novel human gene (designated HALR for "homologous to ALR" and given the 
symbol MLL3 by the HUGO Gene Nomenclature Committee) encodes a predicted large 
hydrophilic nuclear protein. HALR amino acid sequence is present in SUVAR3-9, an 
enhancer of zeste, trithorax (SET) domain, three plant homeodomain (PHD)-type zinc 
fingers, a high motility group (HMG)-1 box, a leucine-zipper-like pattern, two potential 
transactivating domains, several nuclear localization signals, and multiple nuclear 
receptor interaction signature motifs. Especially within the SET domain, PHD fingers 
and several other regions, the HALR protein exhibits significant similarity to ALR 
(acute lymphoblastic leukemia (ALL)-1 related), ALL-1/myeloid/lymphoid or mixed-
lineage leukemia (ALL-1/MLL), and trithorax, evolutionarily conserved proteins that 
influence differentiation and development. (Tan and Chow 2001) isolated the partial 
cDNA of the murine homologue of HALR, which displays high homology to its human 
counterpart. Taking into consideration its notable protein motifs, ubiquitous expression, 
evolutionary conservation and chromosomal position, HALR is likely to play a 
housekeeping role in transcriptional regulation, and may be involved in leukemogenesis 
and developmental disorders. 
 
The identification of several promising interacting partners in this work strongly 
suggests that transcriptional regulation is mainly executed by these interacting and 
potentially other interacting proteins. The fact that TWIST may potentially play critical 
roles in other unknown regulatory pathways leaves open the possibility of additional 
regulatory factors or novel mechanisms being discovered in the future. In order to fully 
elucidate this transcriptional mechanism, further studies are needed to fill gaps of 
knowledge.  
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5 Summary 
Saethre-Chotzen syndrome is an autosomal dominant inherited disorder with premature 
fusion of cranial sutures. It is caused by nucleotide sequence changes within or in 
proximity of the TWIST1 gene. This gene encodes for a bHLH transcription factor, 
which inhibits osteogenic differentiation by transcriptional control of various target 
genes. The aim of my work is to characterize functional domains in TWIST protein, and 
to determine the interacting partner for TWIST and its motifs particularly NSEEE and 
WR. The present study was thus undertaken to determine how TWIST1 gene mutations 
affect protein function. Evolutionary alignment of Twist proteins from different species, 
indicate TWIST contain 4 additional conserved regions such as NSEEE, NLS1, NLS2, 
and WR-domain besides the bHLH motif. The bHLH domain is thought to be 
responsible for heterodimerization with other bHLH proteins such as E12 protein or 
SEF2 protein. The functions of NSEEE, NLS1, NLS2, and conserved WR motifs are 
poorly understood at present. 
First, I focused on functional characterization of the NLS1 and NLS2 domains as 
potential nuclear localization signals in TWIST., Specifically the effects of various NLS 
substitutions in TWIST on cellular localization was assayed by immunoflourescence 
assay. In particular, TWIST NLS1 altered at amino acid position K38R was found to be 
retained in the cytoplasm of transiently transfected U2-OS cells, suggesting that NLS1 
is functional and essential for the nuclear transport of TWIST. Additionally, to 
understand the role of the TWIST NLS2 in nuclear localization, amino acid at positions 
73, 76 and 77 were substituted in this motif. These results demonstrated that substitution 
at NLS2 position 76 does not play an essential role in the nuclear localization of 
TWIST, in contrast to the K73R and K77R that inhibit nuclear accumulation. Although 
K76R mutants cannot inhibit nuclear localization by itself, we demonstrate it plays a 
synergistic role with the NLS1 K38R mutation to further reduce nuclear localization. 
This synergistic effect is consistent with the observation that combined K38R (NLS1) 
and K76R (NLS2) mutants dramatically reduced nuclear localization, further suggesting 
that both NLS1 and NLS2 work together in regulating nuclear localization of TWIST 
protein. 
TWIST belongs to class B bHLH proteins which are known to form stable heterodimers 
with members of class A bHLH transcription factors including gene products of E12 and 
E47, respectively. Accordingly, the subcellular localization of NLS1 and NLS2 in 
TWIST protein was investigated in U2-OS cells following co-transfection with E12. The 
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cotransfections with heterodimerization partner E12 and NLS1-mutated TWIST led to a 
compensation of the mislocalization. 
The second aim of my work was to identify the interacting proteins that could influence 
the functionality of TWIST using yeast-two-hybrid assay. I wanted to determine if the 
TWIST protein or its conserved motifs interact with other regulatory proteins to help to 
regulate the TWIST transcriptional activity. Using the entire coding sequence of TWIST1 
gene, an interesting candidate was found belonging to the class A bHLH transcription 
factors that includes the SEF2 gene product. The direct interaction of SEF2 with TWIST 
was verified in a yeast mating assay and then confirmed in an in vivo NLS-rescue assay 
using U2-OS cells, showing that SEF2 forms a heterodimer with TWIST protein and co-
localized into the nucleus. 
Furthermore, two more highly conserved TWIST motifs NSEEE and WR were analyzed 
individually to find out their interacting proteins and their role in regulating the TWIST1 
transcriptional activity. I found more than 1000 yeast clones for NSEEE motif and 120 
clones for WR motif. The second screening of the yeast clones suggested some 
promising candidates protein as interacting partners with the NSEEE motif such as 
ETV5, SURF4, Spastin, Metalloproteinase 2, and ALR-like protein mRNA. By contrast I 
could not detect any interesting interacting partners with the WR domain. A possible 
explanation may be the requirement of bHLH to mediate WR interaction with other 
proteins. 
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